{"parse":{"title":"GATA2 deficiency","pageid":57618746,"revid":847386101,"text":{"*":"<div class=\"mw-parser-output\"><p><b>GATA2 deficiency</b> (also termed <b>GATA2 haploinsufficiency</b> or <b>GATA2 deficiency syndrome</b>) is a recently defined grouping of several disorders caused by common defect, viz., familial or sporadic <a href=\"/wiki/Mutation#By_effect_on_function\" title=\"Mutation\">inactivating mutations</a> in one of the two parental <i><a href=\"/wiki/GATA2\" title=\"GATA2\">GATA2</a></i> <a href=\"/wiki/Gene\" title=\"Gene\">genes</a>. These <a href=\"/wiki/Autosomal_dominant\" class=\"mw-redirect\" title=\"Autosomal dominant\">autosomal dominant</a> mutations cause a reduction, i.e. a <a href=\"/wiki/Haploinsufficiency\" title=\"Haploinsufficiency\">haploinsufficiency</a>, in the cellular levels of the gene's product, <a href=\"/wiki/GATA2\" title=\"GATA2\">GATA2</a>. The GATA2 <a href=\"/wiki/Protein\" title=\"Protein\">protein</a> is a <a href=\"/wiki/Transcription_factor\" title=\"Transcription factor\">transcription factor</a> critical for the <a href=\"/wiki/Embryogenesis\" title=\"Embryogenesis\">embryonic development</a>, maintenance, and functionality of <a href=\"/wiki/Blood\" title=\"Blood\">blood-forming</a>, <a href=\"/wiki/Lymphatic_system\" title=\"Lymphatic system\">lympathic-forming</a>, and other tissue-forming <a href=\"/wiki/Stem_cell\" title=\"Stem cell\">stem cells</a>. In consequence of these mutations, cellular levels of GATA2 are deficient and individuals develop over time hematological, immunological, lymphatic, or other presentations that may begin as apparently benign abnormalities but commonly progress to severe organ (e.g. lung) failure, <a href=\"/wiki/Opportunistic_infection\" title=\"Opportunistic infection\">opportunistic infections</a>, virus infection-induced cancers, the <a href=\"/wiki/Myelodysplastic_syndrome\" title=\"Myelodysplastic syndrome\">myelodysplastic syndrome</a>, and/or <a href=\"/wiki/Leukemia\" title=\"Leukemia\">leukemia</a>. GATA2 deficiency is a life-threatening and <a href=\"/wiki/Precancerous_condition\" title=\"Precancerous condition\">precancerous condition</a>.<sup id=\"cite_ref-pmid28179280_1-0\" class=\"reference\"><a href=\"#cite_note-pmid28179280-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-pmid28643018_2-0\" class=\"reference\"><a href=\"#cite_note-pmid28643018-2\">&#91;2&#93;</a></sup>\n</p><p>The various presentations of GATA2 deficiency include: <b>1)</b> <a href=\"/wiki/MonoMAC\" title=\"MonoMAC\">Monocytopenia and Mycobacterium Avium Complex/Dendritic Cell, Monocyte, B and NK Lymphocyte deficiency</a> (i.e. MonoMAC or MonoMAC/DCML); <b>2)</b> <a href=\"/wiki/Emberger_syndrome\" title=\"Emberger syndrome\">Emberger syndrome</a>; <b>3)</b> familial <a href=\"/wiki/Myelodysplastic_syndrome\" title=\"Myelodysplastic syndrome\">myelodysplastic syndrome</a>/<a href=\"/wiki/Acute_myeloid_leukemia\" title=\"Acute myeloid leukemia\">acute myeloid leukemia</a> (i.e. familial MDS/AML); <b>3)</b> <a href=\"/wiki/Chronic_myelomonocytic_leukemia\" title=\"Chronic myelomonocytic leukemia\">chronic myelomonocytic leukemia</a> (i.e. CMML);  and <b>4)</b> other anomalies such as <a href=\"/wiki/Aplastic_anemia\" title=\"Aplastic anemia\">aplastic anemia</a>, chronic <a href=\"/wiki/Neutropenia\" title=\"Neutropenia\">neutropenia</a>, and wide-ranging <a href=\"/wiki/Immunodeficiency\" title=\"Immunodeficiency\">immunological defects</a>.<sup id=\"cite_ref-pmid28643018_2-1\" class=\"reference\"><a href=\"#cite_note-pmid28643018-2\">&#91;2&#93;</a></sup> Each of these presentations is characterized by a specific constellation of signs and symptoms but often includes signs and symptoms more characteristic of other GATA2 deficiency presentations. Furthermore, individuals with identical <i>GATA2</i> gene mutations can exhibit very different presentations.<sup id=\"cite_ref-pmid28179280_1-1\" class=\"reference\"><a href=\"#cite_note-pmid28179280-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-pmid28643018_2-2\" class=\"reference\"><a href=\"#cite_note-pmid28643018-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-pmid27248996_3-0\" class=\"reference\"><a href=\"#cite_note-pmid27248996-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-pmid24467820_4-0\" class=\"reference\"><a href=\"#cite_note-pmid24467820-4\">&#91;4&#93;</a></sup>\n</p><p>Prior to 2011, MonoMAC and the Emberger syndrome were clinically defined as unrelated <a href=\"/wiki/Genetic_disorders\" class=\"mw-redirect\" title=\"Genetic disorders\">genetic disorders</a>. In 2011, however, all cases of both disorders were found to be caused by inactivating mutations in the <i>GATA2</i> gene. Subsequently, some but not all cases of an expanding list of other well-defined disorders have been attributed to inactivating <i>GATA2</i> mutations.  While MonoMAC, the Emberger syndrome, and the growing list of all other disorders marked by inactivating <i>GATA2</i> gene mutations are now being classified as a single clinical entity termed GATA2 deficiency, MonoMAC and the Emberger syndrome are sometimes still regarded as separate clinical entities.<sup id=\"cite_ref-pmid28643018_2-3\" class=\"reference\"><a href=\"#cite_note-pmid28643018-2\">&#91;2&#93;</a></sup> Here, GATA2 deficiency is taken to include all disorders caused by inactivating <i>GATA2</i> mutations. Defined as such, GATA2 deficiency is an unexpectedly common underlying cause for a growing list of disorders. Importantly, however, its treatment differs critically from that used to treat cases of these disorders which are not due to GATA2 deficiency.<sup id=\"cite_ref-pmid28643018_2-4\" class=\"reference\"><a href=\"#cite_note-pmid28643018-2\">&#91;2&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#History\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Genetics\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Genetics</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#GATA2_gene_mutations\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\"><i>GATA2</i> gene mutations</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Non-mutational_GATA2_deficiency\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">Non-mutational GATA2 deficiency</span></a></li>\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#Other_genetic_abnormalities\"><span class=\"tocnumber\">2.3</span> <span class=\"toctext\">Other genetic abnormalities</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#GATA2_transcription_factor\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">GATA2 transcription factor</span></a></li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#Signs_and_symptoms\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Signs and symptoms</span></a></li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#Pathophysiology\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Pathophysiology</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Hematologic_defects\"><span class=\"tocnumber\">5.1</span> <span class=\"toctext\">Hematologic defects</span></a></li>\n<li class=\"toclevel-2 tocsection-10\"><a href=\"#Immunologic_defects\"><span class=\"tocnumber\">5.2</span> <span class=\"toctext\">Immunologic defects</span></a></li>\n<li class=\"toclevel-2 tocsection-11\"><a href=\"#Lymphedema\"><span class=\"tocnumber\">5.3</span> <span class=\"toctext\">Lymphedema</span></a></li>\n<li class=\"toclevel-2 tocsection-12\"><a href=\"#Hearing_loss\"><span class=\"tocnumber\">5.4</span> <span class=\"toctext\">Hearing loss</span></a></li>\n<li class=\"toclevel-2 tocsection-13\"><a href=\"#Other_defects\"><span class=\"tocnumber\">5.5</span> <span class=\"toctext\">Other defects</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-14\"><a href=\"#Presentations\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Presentations</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-15\"><a href=\"#MonoMAC\"><span class=\"tocnumber\">6.1</span> <span class=\"toctext\">MonoMAC</span></a></li>\n<li class=\"toclevel-2 tocsection-16\"><a href=\"#Emberger_Syndrome\"><span class=\"tocnumber\">6.2</span> <span class=\"toctext\">Emberger Syndrome</span></a></li>\n<li class=\"toclevel-2 tocsection-17\"><a href=\"#Familial_MDS/AML\"><span class=\"tocnumber\">6.3</span> <span class=\"toctext\">Familial MDS/AML</span></a></li>\n<li class=\"toclevel-2 tocsection-18\"><a href=\"#Congenital_neutropenia\"><span class=\"tocnumber\">6.4</span> <span class=\"toctext\">Congenital neutropenia</span></a></li>\n<li class=\"toclevel-2 tocsection-19\"><a href=\"#Other_presentations\"><span class=\"tocnumber\">6.5</span> <span class=\"toctext\">Other presentations</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-20\"><a href=\"#Diagnosis\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">Diagnosis</span></a></li>\n<li class=\"toclevel-1 tocsection-21\"><a href=\"#Treatment\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">Treatment</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-22\"><a href=\"#Family_counseling\"><span class=\"tocnumber\">8.1</span> <span class=\"toctext\">Family counseling</span></a></li>\n<li class=\"toclevel-2 tocsection-23\"><a href=\"#Prevention_of_complications\"><span class=\"tocnumber\">8.2</span> <span class=\"toctext\">Prevention of complications</span></a></li>\n<li class=\"toclevel-2 tocsection-24\"><a href=\"#Bone_marrow_transplantation\"><span class=\"tocnumber\">8.3</span> <span class=\"toctext\">Bone marrow transplantation</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-25\"><a href=\"#Clinical_trials\"><span class=\"tocnumber\">8.3.1</span> <span class=\"toctext\">Clinical trials</span></a></li>\n</ul>\n</li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-26\"><a href=\"#Prognosis\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">Prognosis</span></a></li>\n<li class=\"toclevel-1 tocsection-27\"><a href=\"#References\"><span class=\"tocnumber\">10</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=1\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In 2011, all cases of the previously described disorders of Emberger syndrome<sup id=\"cite_ref-pmid21892158_5-0\" class=\"reference\"><a href=\"#cite_note-pmid21892158-5\">&#91;5&#93;</a></sup> and MonoMAC<sup id=\"cite_ref-pmid21765025_6-0\" class=\"reference\"><a href=\"#cite_note-pmid21765025-6\">&#91;6&#93;</a></sup> as well as some cases of the previously described disorder of familial MDS/AML<sup id=\"cite_ref-pmid21892162_7-0\" class=\"reference\"><a href=\"#cite_note-pmid21892162-7\">&#91;7&#93;</a></sup> were discovered to be due to inactivating mutations in the <i>GATA2</i> gene. Subsequently, numerous studies discovered that a significant percentage of many other well-known <a href=\"/wiki/Hematologic_disease\" title=\"Hematologic disease\">hematological</a>, <a href=\"/wiki/Immune_disorder\" title=\"Immune disorder\">immunological</a>, <a href=\"/wiki/Autoimmune_disease\" title=\"Autoimmune disease\">autoimmune</a>, and <a href=\"/wiki/Infection\" title=\"Infection\">infectious</a> diseases were associated with, and apparently due to, inactivating mutations in the <i>GATA2</i> gene.<sup id=\"cite_ref-pmid28179280_1-2\" class=\"reference\"><a href=\"#cite_note-pmid28179280-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-pmid28643018_2-5\" class=\"reference\"><a href=\"#cite_note-pmid28643018-2\">&#91;2&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Genetics\">Genetics</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=2\" title=\"Edit section: Genetics\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"GATA2_gene_mutations\"><i>GATA2</i> gene mutations</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=3\" title=\"Edit section: GATA2 gene mutations\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Inactivating mutations in the <i>GATA2</i> gene are the primary cause of GATA2 deficiency disorders. This gene is a member of the evolutionarily conserved <a href=\"/wiki/GATA_transcription_factor\" title=\"GATA transcription factor\">GATA transcription factor</a> gene family. All <a href=\"/wiki/Vertebrate\" title=\"Vertebrate\">vertebrate</a> species tested so far, including humans and mice, express 6 GATA genes, <i>GATA1</i> through <i>GATA6</i>.<sup id=\"cite_ref-pmid23048181_8-0\" class=\"reference\"><a href=\"#cite_note-pmid23048181-8\">&#91;8&#93;</a></sup> The human <i>GATA2</i> gene is located on the long (or \"q\") arm of <a href=\"/wiki/Chromosome_3\" title=\"Chromosome 3\">chromosome 3</a> at position 21.3 (i.e. the 3q21.3 locus). It consists of 8 <a href=\"/wiki/Exons\" class=\"mw-redirect\" title=\"Exons\">exons</a>.<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup> Two sites, one more toward the <a href=\"/wiki/Directionality_(molecular_biology)#5&#39;_end\" title=\"Directionality (molecular biology)\">5' end</a>, the second more toward the <a href=\"/wiki/Directionality_(molecular_biology)#3&#39;_end\" title=\"Directionality (molecular biology)\">3' end</a> of the gene code for two <a href=\"/wiki/Zinc_finger\" title=\"Zinc finger\">Zinc finger</a> <a href=\"/wiki/Structural_motif\" title=\"Structural motif\">structural motifs</a>, ZF1 and ZF2, respectively, of the GATA2 transcription factor. ZF1 and ZF2 are critical for regulating the ability of GATA2 transcription factor to stimulate its target genes.<sup id=\"cite_ref-pmid28637621_10-0\" class=\"reference\"><a href=\"#cite_note-pmid28637621-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-pmid28179282_11-0\" class=\"reference\"><a href=\"#cite_note-pmid28179282-11\">&#91;11&#93;</a></sup>\n</p><p>The <i>GATA2</i> gene has at least five separate sites which bind nuclear factors that regulate its expression. One particularly important such site is located in <a href=\"/wiki/Intron\" title=\"Intron\">intron</a> 4. This site, termed the 9.5 kb enhancer, is located 9.5 <a href=\"/wiki/Base_pair#Length_measurements\" title=\"Base pair\">kilobases</a> (i.e. kb) down-stream from the gene's <a href=\"/wiki/Gene#Structure\" title=\"Gene\">transcript initiation site</a> and is a critically important <a href=\"/wiki/Enhancer_(genetics)\" title=\"Enhancer (genetics)\">enhancer</a> of the gene's expression.<sup id=\"cite_ref-pmid28637621_10-1\" class=\"reference\"><a href=\"#cite_note-pmid28637621-10\">&#91;10&#93;</a></sup> Regulation of <i>GATA2</i> expression is highly complex. For example, in hematological stem cells, GATA2 transcription factor itself binds to one of these sites and in doing so is part of functionally important <a href=\"/wiki/Positive_feedback\" title=\"Positive feedback\">positive feedback</a> <a href=\"/wiki/Autoregulation\" title=\"Autoregulation\">autoregulation circuit</a> wherein the transcription factor acts to promote its own production; in a second example of a positive feed back circuit, GATA2 stimulates production of <a href=\"/wiki/Interleukin_1_beta\" title=\"Interleukin 1 beta\">Interleukin 1 beta</a> and <a href=\"/wiki/CXCL2\" title=\"CXCL2\">CXCL2</a> which act indirectly to simulate <i>GATA2</i> expression. In an example of a <a href=\"/wiki/Negative_feedback\" title=\"Negative feedback\">negative feedback</a> circuit, the GATA2 transcription factor indirectly causes activation of the <a href=\"/wiki/G_protein_coupled_receptor\" class=\"mw-redirect\" title=\"G protein coupled receptor\">G protein coupled receptor</a>, <a href=\"/wiki/GPR65\" title=\"GPR65\">GPR65</a>, which then acts, also indirectly, to repress <i>GATA2</i> gene expression.<sup id=\"cite_ref-pmid28637621_10-2\" class=\"reference\"><a href=\"#cite_note-pmid28637621-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-pmid28179282_11-1\" class=\"reference\"><a href=\"#cite_note-pmid28179282-11\">&#91;11&#93;</a></sup> In a second example of negative feed-back, GATA2 transcription factor stimulates the expression of the <a href=\"/wiki/GATA1\" title=\"GATA1\">GATA1</a> transcription factor which in turn can displace GATA2 transcription factor from its gene-stimulating binding sites thereby limiting GATA2's actions (see GATA2 switch in \"GATA2 transcription factor\" section).<sup id=\"cite_ref-pmid27235756_12-0\" class=\"reference\"><a href=\"#cite_note-pmid27235756-12\">&#91;12&#93;</a></sup>\n</p><p>The human <i>GATA2</i> gene is <a href=\"/wiki/Gene_expression\" title=\"Gene expression\">expressed</a> in hematological bone marrow cells at the <a href=\"/wiki/Stem_cell\" title=\"Stem cell\">stem cell</a> and later <a href=\"/wiki/Progenitor_cell\" title=\"Progenitor cell\">progenitor cell</a> stages of their <a href=\"/wiki/Cellular_differentiation\" title=\"Cellular differentiation\">development</a>. Increases and/or decreases in the gene's expression regulate the <a href=\"/wiki/Stem_cell#self-renewal\" title=\"Stem cell\">self-renewal</a>, survival, and progression of these immature cells toward their final mature forms viz., <a href=\"/wiki/Erythrocytes\" class=\"mw-redirect\" title=\"Erythrocytes\">erythrocytess</a>, certain types of <a href=\"/wiki/Lymphocyte\" title=\"Lymphocyte\">lymphocytes</a> (i.e. <a href=\"/wiki/B_cells\" class=\"mw-redirect\" title=\"B cells\">B cells</a>, <a href=\"/wiki/NK_cells\" class=\"mw-redirect\" title=\"NK cells\">NK cells</a>, and <a href=\"/wiki/T_helper_cells\" class=\"mw-redirect\" title=\"T helper cells\">T helper cells</a>), <a href=\"/wiki/Monocytes\" class=\"mw-redirect\" title=\"Monocytes\">monocytes</a>, <a href=\"/wiki/Neutrophils\" class=\"mw-redirect\" title=\"Neutrophils\">neutrophils</a>, <a href=\"/wiki/Platelet\" title=\"Platelet\">platelets</a>, <a href=\"/wiki/Plasmacytoid_dendritic_cells\" class=\"mw-redirect\" title=\"Plasmacytoid dendritic cells\">plasmacytoid dendritic cells</a>, <a href=\"/wiki/Macrophages\" class=\"mw-redirect\" title=\"Macrophages\">macrophages</a> and mast cells.<sup id=\"cite_ref-pmid28637621_10-3\" class=\"reference\"><a href=\"#cite_note-pmid28637621-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-pmid24227816_13-0\" class=\"reference\"><a href=\"#cite_note-pmid24227816-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-pmid29452225_14-0\" class=\"reference\"><a href=\"#cite_note-pmid29452225-14\">&#91;14&#93;</a></sup> The gene is likewise critical for the formation of the <a href=\"/wiki/Lymphatic_system\" title=\"Lymphatic system\">lymphatic system</a>, particularly for the development of its valves. The human gene is also expressed in <a href=\"/wiki/Endothelium\" title=\"Endothelium\">endothelium</a>, some non-hematological stem cells, the <a href=\"/wiki/Central_nervous_system\" title=\"Central nervous system\">central nervous system</a>, and, to lesser extents, prostate, endometrium, and certain cancerous tissues.<sup id=\"cite_ref-pmid28179280_1-3\" class=\"reference\"><a href=\"#cite_note-pmid28179280-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-pmid23048181_8-1\" class=\"reference\"><a href=\"#cite_note-pmid23048181-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-pmid28637621_10-4\" class=\"reference\"><a href=\"#cite_note-pmid28637621-10\">&#91;10&#93;</a></sup>\n</p><p>Scores of different types of inactivating <i>GATA</i> mutations have been associated with GATA2 deficiency; these include <a href=\"/wiki/Frameshift_mutation\" title=\"Frameshift mutation\">frameshift</a>, <a href=\"/wiki/Point_mutation\" title=\"Point mutation\">point</a>, <a href=\"/wiki/Insertion_(genetics)\" title=\"Insertion (genetics)\">insertion</a>, <a href=\"/wiki/Splice_site_mutation\" title=\"Splice site mutation\">splice site</a> and <a href=\"/wiki/Deletion_(genetics)\" title=\"Deletion (genetics)\">deletion</a> mutations scattered throughout the gene but concentrated in the region encoding the GATA2 transcription factor's ZF1, ZF2, and 9.5 kb sites. Rare cases of GATA2 deficiency involve large mutational deletions that include the 3q21.3 locus plus contiguous adjacent genes; these mutations seem more likely than other types of <i>GATA</i> mutations to cause increased susceptibilities to viral infections, developmental lymphatic disorders, and neurological disturbances.<sup id=\"cite_ref-pmid28179280_1-4\" class=\"reference\"><a href=\"#cite_note-pmid28179280-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-pmid24227816_13-1\" class=\"reference\"><a href=\"#cite_note-pmid24227816-13\">&#91;13&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Non-mutational_GATA2_deficiency\">Non-mutational GATA2 deficiency</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=4\" title=\"Edit section: Non-mutational GATA2 deficiency\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Analyses of individuals with AML have discovered many cases of GATA2 deficiency in which one parental <i>GATA2</i> gene was not mutated but <a href=\"/wiki/Gene_silencing\" title=\"Gene silencing\">silenced</a> by <a href=\"/wiki/DNA_methylation#Repression_of_CpG-dense_promoters\" title=\"DNA methylation\">hypermethylation</a> of its <a href=\"/wiki/Promoter_(genetics)\" title=\"Promoter (genetics)\">gene promotor</a>. Further studies are required to define the involvement of this hypermethylation-induced form of GATA2 deficiency in other disorders as well to integrate it into the diagnostic category of GATA2 deficiency.<sup id=\"cite_ref-pmid25397911_15-0\" class=\"reference\"><a href=\"#cite_note-pmid25397911-15\">&#91;15&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Other_genetic_abnormalities\">Other genetic abnormalities</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=5\" title=\"Edit section: Other genetic abnormalities\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>GATA2 deficiency disorders are variably associated with secondary genetic abnormalities. <a href=\"/wiki/Monosomy\" title=\"Monosomy\">Monosomy</a> of <a href=\"/wiki/Chromosome_7\" title=\"Chromosome 7\">chromosome 7</a> (i.e. lose of one of the two chromosomes 7) or deletion of the \"q\" (i.e. short arm) of one chromosome 7 are the most common abnormal <a href=\"/wiki/Karyotype\" title=\"Karyotype\">karyotypes</a> (i.e. abnormal chromosome number or appearance) associated with GATA2 deficiency, occurring in ~41% of cases; less common abnormal karyotypes associated with the deficiency include chromosome 8 <a href=\"/wiki/Trisomy\" title=\"Trisomy\">trisomy</a> (8% of cases) and, rarely, chromosome 21 monosomy.<sup id=\"cite_ref-pmid28179280_1-5\" class=\"reference\"><a href=\"#cite_note-pmid28179280-1\">&#91;1&#93;</a></sup> GATA2 deficiency is also associated with <a href=\"/wiki/Mutations#somatic_mutations\" class=\"mw-redirect\" title=\"Mutations\">somatic mutaions</a> in at least three other genes viz.,  <i><a href=\"/wiki/ASXL1\" title=\"ASXL1\">ASXL1</a></i>, <i><a href=\"/wiki/SETBP1\" title=\"SETBP1\">SETBP1</a></i>, and <i><a href=\"/wiki/STAG2\" title=\"STAG2\">STAG2</a></i>.<sup id=\"cite_ref-pmid28643018_2-6\" class=\"reference\"><a href=\"#cite_note-pmid28643018-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-pmid28637621_10-5\" class=\"reference\"><a href=\"#cite_note-pmid28637621-10\">&#91;10&#93;</a></sup> Independently of <i><a href=\"/wiki/GATA2\" title=\"GATA2\">GATA2</a></i> mutations and the development of GATA2 deficiency, <i>ASXL1</i> mutations are associated with MDS, AML, CMML, <a href=\"/wiki/Chronic_lymphocytic_leukemia\" title=\"Chronic lymphocytic leukemia\">chronic lymphocytic leukemia</a>, <a href=\"/wiki/Myeloproliferative_neoplasm\" title=\"Myeloproliferative neoplasm\">myeloproliferative neoplasm</a>, and cancers of the breast, cervix, and liver,<sup id=\"cite_ref-pmid23736028_16-0\" class=\"reference\"><a href=\"#cite_note-pmid23736028-16\">&#91;16&#93;</a></sup> <i>SETBP1</i> mutations are associated with atypical MDS, CMML, <a href=\"/wiki/Chronic_myelogenous_leukemia\" title=\"Chronic myelogenous leukemia\">chronic myelogenous leukemia</a>, and <a href=\"/wiki/Chronic_neutrophilic_leukemia\" title=\"Chronic neutrophilic leukemia\">chronic neutrophilic leukemia</a>,<sup id=\"cite_ref-pmid28179280_1-6\" class=\"reference\"><a href=\"#cite_note-pmid28179280-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-pmid26017341_17-0\" class=\"reference\"><a href=\"#cite_note-pmid26017341-17\">&#91;17&#93;</a></sup> and <i>STAG2</i> mutations are associated with MDS, AML, CMML, chronic myelogenous leukemia, and cancers of the bladder, stomach, colon, rectum, and prostate gland.<sup id=\"cite_ref-pmid29278534_18-0\" class=\"reference\"><a href=\"#cite_note-pmid29278534-18\">&#91;18&#93;</a></sup> The roles, if any, of these karyotypes and somatic mutations on the development, types of presentation, and progression of GATA2 deficiency are unclear and require further study.<sup id=\"cite_ref-pmid28179280_1-7\" class=\"reference\"><a href=\"#cite_note-pmid28179280-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-pmid28643018_2-7\" class=\"reference\"><a href=\"#cite_note-pmid28643018-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-pmid28637621_10-6\" class=\"reference\"><a href=\"#cite_note-pmid28637621-10\">&#91;10&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"GATA2_transcription_factor\">GATA2 transcription factor</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=6\" title=\"Edit section: GATA2 transcription factor\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The GATA2 transcription factor contains two <a href=\"/wiki/Zinc_finger\" title=\"Zinc finger\">zinc finger</a> (i.e. ZnF) <a href=\"/wiki/Structural_motif\" title=\"Structural motif\">motifs</a>. C-ZnF is located toward the protein's <a href=\"/wiki/C-terminus\" title=\"C-terminus\">C-terminus</a> and is responsible for binding to specific <a href=\"/wiki/DNA\" title=\"DNA\">DNA</a> sites. N-ZnF is located toward the proteins <a href=\"/wiki/N-terminus\" title=\"N-terminus\">N-terminus</a> and is responsible for interacting with various other <a href=\"/wiki/Cell_nucleus#Cell_compartmentalization\" title=\"Cell nucleus\">nuclear proteins</a> that regulate its activity. The transcription factor also contains two <a href=\"/wiki/Transactivation_domain\" title=\"Transactivation domain\">transactivation domains</a> and one negative regulatory domain which interact with nuclear proteins to up-regulate and down-regulate, respectively, its activity.<sup id=\"cite_ref-pmid28637621_10-7\" class=\"reference\"><a href=\"#cite_note-pmid28637621-10\">&#91;10&#93;</a></sup> In promoting <a href=\"/wiki/Haematopoiesis\" title=\"Haematopoiesis\">haematopoiesis</a> (i.e. maturation of hematological and immunological cells), GATA2 interacts with other <a href=\"/wiki/Transcription_factors\" class=\"mw-redirect\" title=\"Transcription factors\">transcription factors</a> (viz., <a href=\"/wiki/RUNX1\" title=\"RUNX1\">RUNX1</a>, <a href=\"/wiki/TAL1\" title=\"TAL1\">SCL/TAL1</a>, <a href=\"/wiki/GFI1\" title=\"GFI1\">GFI1</a>, <a href=\"/wiki/Cripto\" title=\"Cripto\">GFI1b</a>, <a href=\"/wiki/MYB_(gene)\" title=\"MYB (gene)\">MYB</a>, <a href=\"/wiki/IKZF1\" title=\"IKZF1\">IKZF1</a>, <a href=\"/wiki/SPI1\" title=\"SPI1\">Transcription factor PU.1</a>, <a href=\"/wiki/LYL1\" title=\"LYL1\">LYL1</a>)  and cellular receptors (viz., <a href=\"/wiki/MPL_(gene)\" class=\"mw-redirect\" title=\"MPL (gene)\">MPL</a>, <a href=\"/wiki/GPR56\" title=\"GPR56\">GPR56</a>).<sup id=\"cite_ref-pmid28179282_11-2\" class=\"reference\"><a href=\"#cite_note-pmid28179282-11\">&#91;11&#93;</a></sup>\n</p><p>GATA2 binds to a specific <a href=\"/wiki/Nucleic_acid_sequence\" title=\"Nucleic acid sequence\">nucleic acid sequence</a>  viz., (T/A(GATA)A/G), on the <a href=\"/wiki/Promoter_(genetics)\" title=\"Promoter (genetics)\">promoter</a> and <a href=\"/wiki/Enhancer_(genetics)\" title=\"Enhancer (genetics)\">enhancer</a> sites of its target genes and in doing so either stimulates or suppresses the expression of these target genes. However, there are thousands of sites in human DNA with this nucleotide sequence but, for unknown reasons, GATA2 binds to &lt;1% of these. Furthermore, all members of the GATA transcription factor family bind to this same nucleotide sequence and in doing so may in certain instances serve to interfere with GATA2 binding or even displace the GATA2 that is already bound to these sites. For example, displacement of GATA2 bond to this sequence by the <a href=\"/wiki/GATA1\" title=\"GATA1\">GATA1</a> transcription factor appears important for the normal development of some types of hematological stem cells. This displacement phenomenon is termed the \"GATA switch\". In all events, the actions of GATA2 in regulating its target genes is extremely complex and not fully understood.<sup id=\"cite_ref-pmid28179280_1-8\" class=\"reference\"><a href=\"#cite_note-pmid28179280-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-pmid28637621_10-8\" class=\"reference\"><a href=\"#cite_note-pmid28637621-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-pmid28179282_11-3\" class=\"reference\"><a href=\"#cite_note-pmid28179282-11\">&#91;11&#93;</a></sup><sup id=\"cite_ref-pmid27235756_12-1\" class=\"reference\"><a href=\"#cite_note-pmid27235756-12\">&#91;12&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Signs_and_symptoms\">Signs and symptoms</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=7\" title=\"Edit section: Signs and symptoms\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The age of onset of the GATA2 deficiency is variable with rare individuals showing first signs or symptoms in their infancy and others showing first symptoms or signs at almost any time thereafter including their later years. Rare individuals with inactivating GATA2 mutations may never develop symptoms, i.e. the disorder has a very high but nonetheless incomplete degree of <a href=\"/wiki/Penetrance\" title=\"Penetrance\">penetrance</a>.<sup id=\"cite_ref-pmid21892158_5-1\" class=\"reference\"><a href=\"#cite_note-pmid21892158-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-pmid24227816_13-2\" class=\"reference\"><a href=\"#cite_note-pmid24227816-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-pmid20803646_19-0\" class=\"reference\"><a href=\"#cite_note-pmid20803646-19\">&#91;19&#93;</a></sup> This variability can occur between members of the same family who are documented to have the same <i>GATA2</i> mutation.<sup id=\"cite_ref-pmid28271814_20-0\" class=\"reference\"><a href=\"#cite_note-pmid28271814-20\">&#91;20&#93;</a></sup> The many signs and symptoms that are the direct or indirect consequences of GATA2 deficiency organized based on the types of involvement are:<sup id=\"cite_ref-pmid28179280_1-9\" class=\"reference\"><a href=\"#cite_note-pmid28179280-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-pmid24227816_13-3\" class=\"reference\"><a href=\"#cite_note-pmid24227816-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-pmid29452225_14-1\" class=\"reference\"><a href=\"#cite_note-pmid29452225-14\">&#91;14&#93;</a></sup><sup id=\"cite_ref-pmid20803646_19-1\" class=\"reference\"><a href=\"#cite_note-pmid20803646-19\">&#91;19&#93;</a></sup><sup id=\"cite_ref-pmid23728141_21-0\" class=\"reference\"><a href=\"#cite_note-pmid23728141-21\">&#91;21&#93;</a></sup><sup id=\"cite_ref-pmid25739845_22-0\" class=\"reference\"><a href=\"#cite_note-pmid25739845-22\">&#91;22&#93;</a></sup>\n</p>\n<ul><li>Hematologic: <a href=\"/wiki/Aplastic_anemia\" title=\"Aplastic anemia\">Aplastic anemia</a>, <a href=\"/wiki/Chronic_neutropenia\" class=\"mw-redirect\" title=\"Chronic neutropenia\">chronic neutropenia</a>, <a href=\"/wiki/Monocytopenia\" title=\"Monocytopenia\">monocytopenia</a>, <a href=\"/wiki/Monocytosis\" title=\"Monocytosis\">monocytosis</a> (rarely), <a href=\"/wiki/Thrombocytopenia\" title=\"Thrombocytopenia\">thrombocytopenia</a> (which unlike other hematologic findings is most often due to <a href=\"/wiki/Autoimmunity\" title=\"Autoimmunity\">autoimmunity</a>), <a href=\"/wiki/Bone_marrow_failure\" title=\"Bone marrow failure\">bone marrow failure</a>, <a href=\"/wiki/Myelodysplastic_syndrome\" title=\"Myelodysplastic syndrome\">myelodysplastic syndrome</a>, <a href=\"/wiki/Acute_myeloid_leukemia\" title=\"Acute myeloid leukemia\">acute myeloid leukemia</a>, <a href=\"/wiki/Chronic_myelomonocytic_leukemia\" title=\"Chronic myelomonocytic leukemia\">chronic myelomonocytic leukemia</a>, <a href=\"/wiki/Case_report\" title=\"Case report\">case reports</a> of <a href=\"/wiki/Chronic_lymphocytic_leukemia\" title=\"Chronic lymphocytic leukemia\">chronic lymphocytic leukemia</a> and <a href=\"/wiki/Large_granular_lymphocytic_leukemia\" title=\"Large granular lymphocytic leukemia\">large granular lymphocytic leukemia</a>.</li>\n<li>Lymphatic: <a href=\"/wiki/Lymphedema\" title=\"Lymphedema\">lymphedema</a>, i.e. fluid retention and tissue swelling caused by a compromised <a href=\"/wiki/Lymphatic_system\" title=\"Lymphatic system\">lymphatic system</a> of the lower extremities (often complicated by <a href=\"/wiki/Deep_vein_thrombosis\" title=\"Deep vein thrombosis\">deep vein thrombosis</a> and <a href=\"/wiki/Cellulitis\" title=\"Cellulitis\">cellulitis</a>), lymphedema in other sites such as the face or testes (i.e. <a href=\"/wiki/Hydrocele\" title=\"Hydrocele\">hydrocele</a>).</li>\n<li>Immunologic: Increased susceptibility to infections caused by <a href=\"/wiki/Human_papillomavirus_infection\" title=\"Human papillomavirus infection\"><i>human papillomavirus</i></a>, <i><a href=\"/wiki/Herpes_simplex\" title=\"Herpes simplex\">Herpes simplex</a></i>, <a href=\"/wiki/Varicella_zoster_virus\" title=\"Varicella zoster virus\"><i>Varicella zoster</i> virus</a>, <a href=\"/wiki/Epstein-Barr_virus\" class=\"mw-redirect\" title=\"Epstein-Barr virus\">Epstein-Barr virus</a>, <i><a href=\"/wiki/Cytomegalovirus\" title=\"Cytomegalovirus\">cytomegalovirus</a></i>, <a href=\"/wiki/Molluscum_contagiosum_virus\" title=\"Molluscum contagiosum virus\"><i>Molluscum contagiosum</i> virus</a>, <a href=\"/wiki/Nontuberculous_mycobacteria\" title=\"Nontuberculous mycobacteria\">nontuberculous mycobacteria</a>, other bacteria, various <a href=\"/wiki/Aspergillus\" title=\"Aspergillus\"><i>aspergillus</i> fungus species</a>, various <a href=\"/wiki/Candida_(fungus)\" title=\"Candida (fungus)\"><i>Candida</i> fungus species</a>, and <i><a href=\"/wiki/Histoplasma_capsulatum\" title=\"Histoplasma capsulatum\">histoplasma capsulatum</a></i>;</li>\n<li>Tumors: Increased incidence of <a href=\"/wiki/Human_papillomavirus_infection#Signs_and_symptoms\" title=\"Human papillomavirus infection\"><i>human papillomavirus</i>-induced</a> (e.g. <a href=\"/wiki/Bowenoid_papulosis\" title=\"Bowenoid papulosis\">Bowenoid papulosis</a>, <a href=\"/wiki/Warts\" class=\"mw-redirect\" title=\"Warts\">warts</a>, etc.)) and <a href=\"/wiki/Epstein-Barr_virus#EBV-associated_diseases\" class=\"mw-redirect\" title=\"Epstein-Barr virus\"><i>Epstein-Barr virus</i>-associated</a> (e.g. <a href=\"/wiki/Nasopharynx_cancer\" title=\"Nasopharynx cancer\">nasopharynx cancer</a>, T cell <a href=\"/wiki/Non-Hodgkin_lymphoma\" title=\"Non-Hodgkin lymphoma\">non-Hodgkin lymphoma </a>) benign and malignant tumors.</li>\n<li>Cancers: Increased incidence of <a href=\"/wiki/Melanoma\" title=\"Melanoma\">metastatic melanoma</a>, <a href=\"/wiki/Cervical_carcinoma\" class=\"mw-redirect\" title=\"Cervical carcinoma\">cervical carcinoma</a>, <a href=\"/wiki/Bowen_disease\" class=\"mw-redirect\" title=\"Bowen disease\">Bowen disease</a> of the vulva, <a href=\"/wiki/Spindle_cell_sarcoma\" title=\"Spindle cell sarcoma\">spindle cell sarcoma</a> of the liver, <a href=\"/wiki/Head_and_neck_cancer\" title=\"Head and neck cancer\">head and neck cancers</a>, <a href=\"/wiki/Leiomyosarcoma\" title=\"Leiomyosarcoma\">leiomyosarcoma</a>, <a href=\"/wiki/Pancreas_cancer\" class=\"mw-redirect\" title=\"Pancreas cancer\">pancreas cancer</a>, <a href=\"/wiki/Kidney_cancer\" title=\"Kidney cancer\">kidney cancer</a>, and <a href=\"/wiki/Breast_cancer\" title=\"Breast cancer\">breast cancer</a>.</li>\n<li><a href=\"/wiki/Autoimmunity\" title=\"Autoimmunity\">Autoimmunity</a>: <a href=\"/wiki/Erythema_nodosum\" title=\"Erythema nodosum\">Erythema nodosum</a>, <a href=\"/wiki/Panniculitis\" title=\"Panniculitis\">panniculitis</a>, <a href=\"/wiki/Lupus_erythematosus\" title=\"Lupus erythematosus\">lupus erythematosus</a>-like reactions, <a href=\"/wiki/Immune_thrombocytopenic_purpura\" title=\"Immune thrombocytopenic purpura\">autoimmune thrombocytopenia</a>, chronic <a href=\"/wiki/Arthritis\" title=\"Arthritis\">arthritis</a>, <a href=\"/wiki/Arthralgia\" title=\"Arthralgia\">arthralgias</a>,<a href=\"/wiki/Primary_biliary_cirrhosis\" class=\"mw-redirect\" title=\"Primary biliary cirrhosis\">primary biliary cirrhosis</a>, aggressive <a href=\"/wiki/Multiple_sclerosis\" title=\"Multiple sclerosis\">multiple sclerosis</a>.</li>\n<li>Lung: <a href=\"/wiki/Pulmonary_alveolar_proteinosis\" title=\"Pulmonary alveolar proteinosis\">Pulmonary alveolar proteinosis</a> (unlike most other cases of pulmonary alveolar proteinosis, the GATA2 deficiency-induced lung disorder is not caused by autoimmunity to or other causes for sharp reductions in <a href=\"/wiki/Granulocyte-macrophage_colony_stimulating_factor\" class=\"mw-redirect\" title=\"Granulocyte-macrophage colony stimulating factor\">granulocyte-macrophage colony stimulating factor</a>); <a href=\"/wiki/Cryptogenic_organizing_pneumonia\" title=\"Cryptogenic organizing pneumonia\">cryptogenic organizing pneumonia</a>-like disease, <a href=\"/wiki/Pulmonary_artery_hypertension\" class=\"mw-redirect\" title=\"Pulmonary artery hypertension\">pulmonary artery hypertension</a>; pulmonary ventilation and diffusion defects as defined by <a href=\"/wiki/Pulmonary_function_testing\" title=\"Pulmonary function testing\">pulmonary function testing</a> that may lead to <a href=\"/wiki/Respiratory_failure\" title=\"Respiratory failure\">respiratory failure</a>.</li>\n<li>Neuorlogic: <a href=\"/wiki/Sensorineural_hearing_loss\" title=\"Sensorineural hearing loss\">Sensorineural hearing loss</a> mainly for high frequencies.</li>\n<li>Heart: <a href=\"/wiki/Endocarditis\" title=\"Endocarditis\">Endocarditis</a> (may reflect GATA2 deficiency in the endocardium and/or impaired overlap with GATA4 function, which is involved in the embryonic development of this organ).</li>\n<li>Thyroid gland: Idiopathic (i.e. unknown cause) <a href=\"/wiki/Hypothyroidism\" title=\"Hypothyroidism\">hypothyroidism</a>.</li>\n<li>Reproductive: High rate of <a href=\"/wiki/Miscarriage\" title=\"Miscarriage\">miscarriage</a>.</li>\n<li><a href=\"/wiki/Body_dysmorphic_disorder\" title=\"Body dysmorphic disorder\">Body dysmorphic disorders</a>: <a href=\"/wiki/Hypotelorism\" title=\"Hypotelorism\">Hypotelorism</a>, <a href=\"/wiki/Epicanthic_folds\" class=\"mw-redirect\" title=\"Epicanthic folds\">epicanthic folds</a>, <a href=\"/wiki/Webbed_neck\" title=\"Webbed neck\">webbed neck</a>, small <a href=\"/wiki/Palpebral_fissures\" class=\"mw-redirect\" title=\"Palpebral fissures\">palpebral fissures</a>, <a href=\"/wiki/Ptosis_(eyelid)\" title=\"Ptosis (eyelid)\">ptosis</a>, <a href=\"/wiki/Strabismus\" title=\"Strabismus\">strabismus</a>, <a href=\"/wiki/Genitourinary_system#Disorders\" title=\"Genitourinary system\">urogenital malformations</a>.</li>\n<li><a href=\"/wiki/Emotional_and_behavioral_disorders\" title=\"Emotional and behavioral disorders\">Emotional and behavioral disorders</a>: <a href=\"/wiki/Autism_spectrum\" title=\"Autism spectrum\">Autism spectrum disorders</a>, <a href=\"/wiki/Chronic_headache\" class=\"mw-redirect\" title=\"Chronic headache\">chronic headache</a>.</li></ul>\n<h2><span class=\"mw-headline\" id=\"Pathophysiology\">Pathophysiology</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=8\" title=\"Edit section: Pathophysiology\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Hematologic_defects\">Hematologic defects</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=9\" title=\"Edit section: Hematologic defects\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Deletion of both <i>Gata2</i> genes in mice is lethal by day 10 of embryogenesis due to a total failure in the <a href=\"/wiki/Hematopoiesis\" class=\"mw-redirect\" title=\"Hematopoiesis\">formation of mature blood cells</a>. Inactivation of one mouse <i>Gata2</i> gene is neither lethal nor associated with most of the signs of human GATA2 deficiency; however, these animals do show a ~50% reduction in their <a href=\"/wiki/Hematopoietic_stem_cell\" title=\"Hematopoietic stem cell\">hematopoietic stem cells</a> along with a reduced ability to repopulate the bone marrow of mouse recipients. The latter findings, human clinical studies, and experiments on human tissues support the conclusion that in humans both parental <i>GATA2</i> genes are required for sufficient numbers of hematopoietic stem cells to emerge from the <a href=\"/wiki/Hemogenic_endothelium\" title=\"Hemogenic endothelium\">hemogenic endothelium</a> during <a href=\"/wiki/Embryogenesis\" title=\"Embryogenesis\">embryogenesis</a> and for these cells and subsequent <a href=\"/wiki/Progenitor_cells\" class=\"mw-redirect\" title=\"Progenitor cells\">progenitor cells</a> to survive, <a href=\"/wiki/Stem_cell#self-renewal\" title=\"Stem cell\">self-renew</a>, and  <a href=\"/wiki/Cellular_differentiation\" title=\"Cellular differentiation\">differentiate</a> into mature cells.<sup id=\"cite_ref-pmid28637621_10-9\" class=\"reference\"><a href=\"#cite_note-pmid28637621-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-pmid24227816_13-4\" class=\"reference\"><a href=\"#cite_note-pmid24227816-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-pmid25397911_15-1\" class=\"reference\"><a href=\"#cite_note-pmid25397911-15\">&#91;15&#93;</a></sup> As GATA2 deficient individuals age, their deficiency in hematopoietic stem cells worsens, probably as a result of factors such as infections or other stresses. In consequence, the signs and symptoms of their disease appear and/or become progressively more severe.<sup id=\"cite_ref-pmid25619630_23-0\" class=\"reference\"><a href=\"#cite_note-pmid25619630-23\">&#91;23&#93;</a></sup>\n</p><p>MonoMAC-afflicted individuals exhibit reduced levels of <a href=\"/wiki/Lymphopoiesis#Stages_of_development\" title=\"Lymphopoiesis\">common lymphoid progenitor cells</a> (i.e. a heterogenous group of precursors to various <a href=\"/wiki/Lymphocyte\" title=\"Lymphocyte\">lymphocyte</a> types) and <a href=\"/wiki/Granulocyte-macrophage_progenitor\" class=\"mw-redirect\" title=\"Granulocyte-macrophage progenitor\">granulocyte-macrophage progenitor</a> cells (i.e. precursors to <a href=\"/wiki/Granulocytes\" class=\"mw-redirect\" title=\"Granulocytes\">granulocytes</a> and <a href=\"/wiki/Monocytes\" class=\"mw-redirect\" title=\"Monocytes\">monocytes</a>).<sup id=\"cite_ref-pmid21242295_24-0\" class=\"reference\"><a href=\"#cite_note-pmid21242295-24\">&#91;24&#93;</a></sup> In mice and presumably humans, GATA2 deficiency also leads to reduced levels of early <a href=\"/wiki/Erythrocyte\" class=\"mw-redirect\" title=\"Erythrocyte\">erythrocyte</a> stem cells.<sup id=\"cite_ref-pmid24638828_25-0\" class=\"reference\"><a href=\"#cite_note-pmid24638828-25\">&#91;25&#93;</a></sup> While our understanding of human hematopoiesis is incomplete, it is proposed that these or related progenitor cell reductions causes a progressively worsening depletion of circulating and/or tissue bound <a href=\"/wiki/B_cells\" class=\"mw-redirect\" title=\"B cells\">B cells</a>, <a href=\"/wiki/NK_cells\" class=\"mw-redirect\" title=\"NK cells\">NK cells</a>, <a href=\"/wiki/T_helper_cells\" class=\"mw-redirect\" title=\"T helper cells\">T helper cells</a>, <a href=\"/wiki/Monocytes\" class=\"mw-redirect\" title=\"Monocytes\">monocytes</a>, <a href=\"/wiki/Plasmacytoid_dendritic_cells\" class=\"mw-redirect\" title=\"Plasmacytoid dendritic cells\">plasmacytoid dendritic cells</a>,  <a href=\"/wiki/Neutrophils\" class=\"mw-redirect\" title=\"Neutrophils\">neutrophils</a>, and/or <a href=\"/wiki/Red_blood_cells\" class=\"mw-redirect\" title=\"Red blood cells\">red blood cells</a>. In consequence, GATA2 deficient individuals may exhibit the clinically significant disorders of chronic <a href=\"/wiki/Neutropenia\" title=\"Neutropenia\">neutropenia</a>, <a href=\"/wiki/Aplastic_anemia\" title=\"Aplastic anemia\">aplastic anemia</a>, <a href=\"/wiki/Bone_marrow_failure\" title=\"Bone marrow failure\">bone marrow failure</a>, or the <a href=\"/wiki/Myelodysplastic_syndrome\" title=\"Myelodysplastic syndrome\">myelodysplastic syndrome</a>.<sup id=\"cite_ref-pmid28179282_11-4\" class=\"reference\"><a href=\"#cite_note-pmid28179282-11\">&#91;11&#93;</a></sup><sup id=\"cite_ref-pmid24227816_13-5\" class=\"reference\"><a href=\"#cite_note-pmid24227816-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-pmid29452225_14-2\" class=\"reference\"><a href=\"#cite_note-pmid29452225-14\">&#91;14&#93;</a></sup> However, the role of GATA2 deficiency in leading to a leukemias is not understood, particularly since mutations which increase the activity of this transcription factor appear to be associated with the progression of non-familial AML as well as development of the blast crisis in <a href=\"/wiki/Chronic_myelogenous_leukemia#Blast_crisis\" title=\"Chronic myelogenous leukemia\">chronic myelogenous leukemia</a>.<sup id=\"cite_ref-pmid28179282_11-5\" class=\"reference\"><a href=\"#cite_note-pmid28179282-11\">&#91;11&#93;</a></sup><sup id=\"cite_ref-pmid25619630_23-1\" class=\"reference\"><a href=\"#cite_note-pmid25619630-23\">&#91;23&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Immunologic_defects\">Immunologic defects</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=10\" title=\"Edit section: Immunologic defects\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The depletion of hematologic cells, particularly <a href=\"/wiki/Dendritic_cells\" class=\"mw-redirect\" title=\"Dendritic cells\">dendritic cells</a>, caused by GATA2 deficiency (see previous section) also appears responsible for the development of defective <a href=\"/wiki/Innate_immune_system\" title=\"Innate immune system\">innate</a> and <a href=\"/wiki/Adaptive_immune_system\" title=\"Adaptive immune system\">adaptive</a> immune responses. In consequence, these individuals become increasing susceptibility to infectious agents and to cancers caused by infective agents. This defect in mounting immune responses is mostly restricted to new antigenic challenges. That is, <a href=\"/wiki/Immune_response\" title=\"Immune response\">secondary immune responses</a> to which individuals had mounted effective <a href=\"/wiki/Immune_responses\" class=\"mw-redirect\" title=\"Immune responses\">primary immune responses</a> before GATA2 deficiency paralyzed their immune system generally remain intact. Immune system deterioration would also appear responsible for the development of the pathological <a href=\"/wiki/Autoimmunity\" title=\"Autoimmunity\">autoimmune reactions</a> which afflicted individuals may mount against their own tissues.<sup id=\"cite_ref-pmid28179282_11-6\" class=\"reference\"><a href=\"#cite_note-pmid28179282-11\">&#91;11&#93;</a></sup><sup id=\"cite_ref-pmid24227816_13-6\" class=\"reference\"><a href=\"#cite_note-pmid24227816-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-pmid29452225_14-3\" class=\"reference\"><a href=\"#cite_note-pmid29452225-14\">&#91;14&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Lymphedema\">Lymphedema</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=11\" title=\"Edit section: Lymphedema\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The GATA2 transcription factor contributes to controlling the expression of two genes, <i><a href=\"/wiki/PROX1\" title=\"PROX1\">PROX1</a></i> and <i><a href=\"/wiki/FOXC2\" title=\"FOXC2\">FOXC2</a></i>, which are required for the proper development of the lymphathic system, particularly lymph vessel valves. It is proposed that GATA2 deficiency causes a failure to develop competent valves and/or vessels in the <a href=\"/wiki/Lymphatic_system\" title=\"Lymphatic system\">lymphatic system</a> and thereby leads to <a href=\"/wiki/Lymphedema\" title=\"Lymphedema\">lymphedema</a>.<sup id=\"cite_ref-pmid28643018_2-8\" class=\"reference\"><a href=\"#cite_note-pmid28643018-2\">&#91;2&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Hearing_loss\">Hearing loss</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=12\" title=\"Edit section: Hearing loss\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>GATA2 deficiency-induced abnormalities in the lymphatic system are also proposed to be responsible for a failure in generating the <a href=\"/wiki/Perilymphatic_space\" class=\"mw-redirect\" title=\"Perilymphatic space\">perilymphatic space</a> around the inner ear's <a href=\"/wiki/Semicircular_canals\" title=\"Semicircular canals\">semicircular canals</a>, which in turn underlies the development of sensorineural hearing loss in GATA2 deficient individuals, particularly those diagnosed with the Emberger syndrome.<sup id=\"cite_ref-pmid28643018_2-9\" class=\"reference\"><a href=\"#cite_note-pmid28643018-2\">&#91;2&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Other_defects\">Other defects</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=13\" title=\"Edit section: Other defects\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The pathophysiology behind the other defects associated with GATA2 deficiency such as hypothyroidism, endocarditis, pulmonary alveolar proteinosis; cryptogenic organizing pneumonia-like disease, pulmonary hypertension, pulmonary ventilator and diffusion defects, miscarriages, etc., is as yet undefined. It is possible that many of these other defects are secondary, i.e. associated with GATA2 deficiency but not a direct result of low cellular levels of the GATA2 transcription factor.\n</p>\n<h2><span class=\"mw-headline\" id=\"Presentations\">Presentations</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=14\" title=\"Edit section: Presentations\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The presentations of GATA2 deficiency commonly fall into various categories with MonoMAC and Emberger syndrome in the past and sometimes even currently being considered as separate entities. In most cases, the age of onset and initial signs and symptoms are variable with each presentation often being accompanied by signs or symptoms more typical of other presentations. Nonetheless, most cases of the deficiency exhibit a combination of signs and symptoms that fit the following presentations.\n</p>\n<h3><span class=\"mw-headline\" id=\"MonoMAC\">MonoMAC</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=15\" title=\"Edit section: MonoMAC\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/MonoMAC\" title=\"MonoMAC\">MonoMAC</a></div>\n<p>Individuals afflicted with MonoMAC commonly present in early adulthood afflicted with one or more of the <a href=\"/wiki/Opportunistic_infection\" title=\"Opportunistic infection\">opportunistic infections</a> listed in the above Signs and symptoms section and have profoundly low numbers of circulating <a href=\"/wiki/Monocyte\" title=\"Monocyte\">monocytes</a> which may have existed for many years before symptoms developed.<sup id=\"cite_ref-pmid23728141_21-1\" class=\"reference\"><a href=\"#cite_note-pmid23728141-21\">&#91;21&#93;</a></sup> These individuals also have low numbers of two other types of circulating blood cells viz., <a href=\"/wiki/B_lymphocyte\" class=\"mw-redirect\" title=\"B lymphocyte\">B lymphocytes</a> and <a href=\"/wiki/NK_cell\" class=\"mw-redirect\" title=\"NK cell\">NK cells</a>. Other presentations and/or developments (see Signs and symptoms)include: <b>1)</b> pulmonary alveolar proteinosis; <b>2)</b> tumors caused by opportunistic viral infections; <b>3)</b> autoimmunity disturbances; and <b>4)</b> the myelodysplastic syndrome, acute myeloblastic leukemia, or chronic myelomonocytic leukemia.<sup id=\"cite_ref-pmid23728141_21-2\" class=\"reference\"><a href=\"#cite_note-pmid23728141-21\">&#91;21&#93;</a></sup><sup id=\"cite_ref-pmid25739845_22-1\" class=\"reference\"><a href=\"#cite_note-pmid25739845-22\">&#91;22&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Emberger_Syndrome\">Emberger Syndrome</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=16\" title=\"Edit section: Emberger Syndrome\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Emberger_syndrome\" title=\"Emberger syndrome\">Emberger syndrome</a></div>\n<p>Emberger syndrome presents as early as infancy but more typically in childhood or early adulthood with <a href=\"/wiki/Lymphedema\" title=\"Lymphedema\">lymphedema</a> of the lower limbs or <a href=\"/wiki/Testes\" class=\"mw-redirect\" title=\"Testes\">testes</a>, i.e. <a href=\"/wiki/Hydrocele\" title=\"Hydrocele\">hydrocele</a>, and congenital <a href=\"/wiki/Sensorineural_hearing_loss\" title=\"Sensorineural hearing loss\">sensorineural hearing loss</a>. Afflicted individuals may also exhibit one or more of the <a href=\"/wiki/Dysplasia\" title=\"Dysplasia\">dysplasias</a> listed in the above \"Signs and symptoms\" section. These presentations typically occur along side of or are followed by hematalogic abnormalities including but often only after many years or decades seriously life-threatening <a href=\"/wiki/Myelodysplastic_syndrome\" title=\"Myelodysplastic syndrome\">myelodysplastic syndrome</a> and/or <a href=\"/wiki/Acute_myeloid_leukemia\" title=\"Acute myeloid leukemia\">acute myeloid leukemia</a>.<sup id=\"cite_ref-pmid28643018_2-10\" class=\"reference\"><a href=\"#cite_note-pmid28643018-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-pmid21892158_5-2\" class=\"reference\"><a href=\"#cite_note-pmid21892158-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-pmid20803646_19-2\" class=\"reference\"><a href=\"#cite_note-pmid20803646-19\">&#91;19&#93;</a></sup> Individuals afflicted by the syndrome may also exhibit increased susceptibility to opportunistic viral infections, particularly in individuals that have <a href=\"/wiki/Null_allele\" title=\"Null allele\">Null mutations</a> (i.e. mutations that cause complete lose of a functional gene product) in the <i>GATA2</i> gene.<sup id=\"cite_ref-pmid25619630_23-2\" class=\"reference\"><a href=\"#cite_note-pmid25619630-23\">&#91;23&#93;</a></sup>\n</p>\n<h3><span id=\"Familial_MDS.2FAML\"></span><span class=\"mw-headline\" id=\"Familial_MDS/AML\">Familial MDS/AML</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=17\" title=\"Edit section: Familial MDS/AML\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Myelodysplastic_syndrome\" title=\"Myelodysplastic syndrome\">Myelodysplastic syndrome</a></div>\n<p>Familial MDS/AML is an inherited predisposition to develop MDS, i.e. a disorder characterized by the development of a genetically distinct subpopulation (i.e. clone) of bone marrow <a href=\"/wiki/Hematopoietic_stem_cell\" title=\"Hematopoietic stem cell\">hematopoietic stem cells</a>,  decreased levels of one or more types of circulating blood cells, and an increased risk of progressing to leukemia, particularly AML.<sup id=\"cite_ref-pmid29438960_26-0\" class=\"reference\"><a href=\"#cite_note-pmid29438960-26\">&#91;26&#93;</a></sup> GATA2 deficiency commonly presents as MDS in childhood (usually &gt;4 years of age) and adolescent (generally &lt;18 years of age) individuals and as such is the most common <a href=\"/wiki/Germline_mutation\" title=\"Germline mutation\">germline mutation</a> responsible for familial MDS/AML in this age group.<sup id=\"cite_ref-pmid27913534_27-0\" class=\"reference\"><a href=\"#cite_note-pmid27913534-27\">&#91;27&#93;</a></sup> Inactivating <i>GATA2</i> mutations appear responsible for ~15% in cases of advanced familial MDS (i.e. cases in which hematologic <a href=\"/wiki/Blast_cell\" class=\"mw-redirect\" title=\"Blast cell\">blast cells</a> are \u22652% in blood or \u22652% but \u226420% in bone marrow) and in 4% of cases diagnosed as low-grade familial MDS (i.e. blast cells are &lt;2% in blood or &lt;5% in blood). Individuals exhibiting &gt;20% blast cells in blood or bone marrow are diagnosed as having AML. Thus, GATA2 deficiency may also present as AML that was preceded by MPS.<sup id=\"cite_ref-pmid29438960_26-1\" class=\"reference\"><a href=\"#cite_note-pmid29438960-26\">&#91;26&#93;</a></sup><sup id=\"cite_ref-pmid27913534_27-1\" class=\"reference\"><a href=\"#cite_note-pmid27913534-27\">&#91;27&#93;</a></sup><sup id=\"cite_ref-pmid29156196_28-0\" class=\"reference\"><a href=\"#cite_note-pmid29156196-28\">&#91;28&#93;</a></sup> In about 70% of the cases, the inactivating <i>GATA2</i> mutations found in Familial MDS/AML are associated with advanced disease and exhibit <a href=\"/wiki/Monosomy\" title=\"Monosomy\">monosomy</a> of their 7 chromosome.<sup id=\"cite_ref-pmid27913534_27-2\" class=\"reference\"><a href=\"#cite_note-pmid27913534-27\">&#91;27&#93;</a></sup> GATA2 deficiency-induced familial MDS/AML is often diagnosed in one member of a family that has other members with identical <i>GATA2</i> gene mutations but either are classified as having another type of GATA2 deficiency presentation or have no signs or symptoms whatsoever of GATA2 deficiency.<sup id=\"cite_ref-pmid28643018_2-11\" class=\"reference\"><a href=\"#cite_note-pmid28643018-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-pmid27913534_27-3\" class=\"reference\"><a href=\"#cite_note-pmid27913534-27\">&#91;27&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Congenital_neutropenia\">Congenital neutropenia</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=18\" title=\"Edit section: Congenital neutropenia\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Neutropenia\" title=\"Neutropenia\">Neutropenia</a></div>\n<p>Congenital neutropenia refers to an assorted group of diseases that share a common set of signs and symptoms, viz., <a href=\"/wiki/Neutropenia\" title=\"Neutropenia\">neutropenia</a>, i.e. a low circulating blood <a href=\"/wiki/Neutrophil\" title=\"Neutrophil\">neutrophil</a> count, increased susceptibility to infections, various organ dysfunctions, and an extraordinarily high risk of developing leukemia.<sup id=\"cite_ref-pmid28875503_29-0\" class=\"reference\"><a href=\"#cite_note-pmid28875503-29\">&#91;29&#93;</a></sup> A small percentage of individuals with familial or sporadic GATA2 deficiency present in their childhood with <a href=\"/wiki/Asymptomatic\" title=\"Asymptomatic\">asymptomatic</a> mild neutropenia but no other discernible hematological abnormalities except perhaps <a href=\"/wiki/Monocytopenia\" title=\"Monocytopenia\">monocytopenia</a> and <a href=\"/wiki/Macrocytosis\" title=\"Macrocytosis\">macrocytosis</a>, i.e. enlarged <a href=\"/wiki/Red_blood_cell\" title=\"Red blood cell\">red blood cells</a>. This presentation often persists for years but commonly progresses to include <a href=\"/wiki/Thrombocytopenia\" title=\"Thrombocytopenia\">thrombocytopenia</a>, increases susceptibility to infections due to, e.g. atypical mycobacteria or <a href=\"/wiki/Human_papillomavirus_infection\" title=\"Human papillomavirus infection\">human papillomavirus</a>, dysfunction of non-hematological organs, MDS, and leukemia (primarily AML and less commonly CMML). It is estimated that by age 30, 60% of these individuals develop leukemia.<sup id=\"cite_ref-pmid28643018_2-12\" class=\"reference\"><a href=\"#cite_note-pmid28643018-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-pmid24467820_4-1\" class=\"reference\"><a href=\"#cite_note-pmid24467820-4\">&#91;4&#93;</a></sup><sup id=\"cite_ref-pmid25619630_23-3\" class=\"reference\"><a href=\"#cite_note-pmid25619630-23\">&#91;23&#93;</a></sup><sup id=\"cite_ref-pmid28875503_29-1\" class=\"reference\"><a href=\"#cite_note-pmid28875503-29\">&#91;29&#93;</a></sup> Some of these individuals have large deletion mutations that span the <i>GATA2</i> along with nearby genes and exhibit in addition to hematological defects various developmental abnormalities, neurological abnormalities, and/or body dysmorphic disorders.<sup id=\"cite_ref-pmid29296959_30-0\" class=\"reference\"><a href=\"#cite_note-pmid29296959-30\">&#91;30&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Other_presentations\">Other presentations</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=19\" title=\"Edit section: Other presentations\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Aplastic_anemia\" title=\"Aplastic anemia\">Aplastic anemia</a></div>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Bone_marrow_failure\" title=\"Bone marrow failure\">Bone marrow failure</a></div>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Humoral_immune_deficiency\" title=\"Humoral immune deficiency\">Humoral immune deficiency</a></div>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Monocytosis\" title=\"Monocytosis\">Monocytosis</a></div>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Chronic_myelomonocytic_leukemia\" title=\"Chronic myelomonocytic leukemia\">Chronic myelomonocytic leukemia</a></div>\n<p>GATA2 deficiency has been diagnosed in up to 10% of individuals presenting with <a href=\"/wiki/Aplastic_anemia\" title=\"Aplastic anemia\">aplastic anemia</a>. It is also the most common cause of hereditary <a href=\"/wiki/Bone_marrow_failure\" title=\"Bone marrow failure\">bone marrow failure</a> and may present with this disorder. GATA 2 deficiency has been diagnosed in rare cases presenting as <a href=\"/wiki/Humoral_immune_deficiency\" title=\"Humoral immune deficiency\">humoral immune deficiency</a> due to <a href=\"/wiki/B_cell\" title=\"B cell\">B cell</a> depletion, severe <a href=\"/wiki/Epstein%E2%80%93Barr_virus_infection\" title=\"Epstein\u2013Barr virus infection\">Epstein\u2013Barr virus infection</a>, or <a href=\"/wiki/Epstein-Barr_virus_infection#EBV-associated_malignancies\" class=\"mw-redirect\" title=\"Epstein-Barr virus infection\">Epstein-Barr associated cancers</a>. In all of these presentations, individuals may have or develop other manifestations of the deficiency and are of particularly high risk for developing AML or CMML.<sup id=\"cite_ref-pmid28179280_1-10\" class=\"reference\"><a href=\"#cite_note-pmid28179280-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-pmid28643018_2-13\" class=\"reference\"><a href=\"#cite_note-pmid28643018-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-pmid25397911_15-2\" class=\"reference\"><a href=\"#cite_note-pmid25397911-15\">&#91;15&#93;</a></sup>\n</p><p>Rare cases of individuals with GATA2 deficiency may also present with extreme <a href=\"/wiki/Monocytosis\" title=\"Monocytosis\">monocytosis</a> (i.e. increases in circulating blood monocytes) or CMML, i.e. monocytosis plus the presence of abnormal (<a href=\"/wiki/Precursor_cell\" title=\"Precursor cell\">blasts</a>) in the circulation and/or bone marrow. GATA2 deficient individuals who develop CMML often exhibit mutations in one of their <i><a href=\"/wiki/ASXL1\" title=\"ASXL1\">ASXL1</a></i> genes. Since mutations in this gene are associated with  CMML independently of <i>GATA2</i> mutations, <i>ASXL1</i> mutations may promote the development of CMML in GATA2 deficiency.<sup id=\"cite_ref-pmid28179280_1-11\" class=\"reference\"><a href=\"#cite_note-pmid28179280-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-pmid28643018_2-14\" class=\"reference\"><a href=\"#cite_note-pmid28643018-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-pmid25397911_15-3\" class=\"reference\"><a href=\"#cite_note-pmid25397911-15\">&#91;15&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Diagnosis\">Diagnosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=20\" title=\"Edit section: Diagnosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Individuals with GATA2 deficiency commonly exhibit abnormalities in their <a href=\"/wiki/Complete_blood_count\" title=\"Complete blood count\">circulating blood cells</a> (see above \"Hematologic\" section of Signs and symptoms) that may precede other signs and symptoms of the disease by years. Their <a href=\"/wiki/Bone_marrow_biopsy\" class=\"mw-redirect\" title=\"Bone marrow biopsy\">bone marrows</a> typically shows significant reductions in one or more types of blood cell lines (i.e. hypocellularity) with characteristic dysplastic features of increased sizes of cells in the red blood cell line (i.e. macrocytic erythropoiesis), small or enlarged <a href=\"/wiki/Megakaryocyte\" title=\"Megakaryocyte\">megakaryocytes</a>, abnormalities in the maturation of cells in the granulocyte cell line, <a href=\"/wiki/Fibrosis\" title=\"Fibrosis\">fibrosis</a> consisting of <a href=\"/wiki/Reticular_fibers\" class=\"mw-redirect\" title=\"Reticular fibers\">reticular fibers</a>, increased numbers of <a href=\"/wiki/T_cells\" class=\"mw-redirect\" title=\"T cells\">T cells</a> containing numerous large granules in their <a href=\"/wiki/Cytoplasm\" title=\"Cytoplasm\">cytoplasm</a>, and in advanced cases increases in <a href=\"/wiki/Blast_cell\" class=\"mw-redirect\" title=\"Blast cell\">blast cell</a> numbers. The bone marrow in advanced cases may also exhibit increase in cellularity, i.e. hypercellularity.<sup id=\"cite_ref-pmid27913534_27-4\" class=\"reference\"><a href=\"#cite_note-pmid27913534-27\">&#91;27&#93;</a></sup> GATA2 deficient individuals often have highly increased blood levels of <a href=\"/wiki/FMS-like_tyrosine_kinase_3_ligand\" title=\"FMS-like tyrosine kinase 3 ligand\">FMS-like tyrosine kinase 3 ligand</a><sup id=\"cite_ref-pmid25397911_15-4\" class=\"reference\"><a href=\"#cite_note-pmid25397911-15\">&#91;15&#93;</a></sup> However, these as well as other features are diagnostic of a hematologic disorder but not necessarily of GATA2 deficiency. <a href=\"/wiki/DNA_sequencing\" title=\"DNA sequencing\">DNA sequencing</a> of the full <i>GATA2</i> gene <a href=\"/wiki/Coding_region\" title=\"Coding region\">coding region</a> including the <a href=\"/wiki/Intron\" title=\"Intron\">intron</a>4 enhancer by <a href=\"/wiki/Sanger_sequencing\" title=\"Sanger sequencing\">Sanger sequencing</a> or <a href=\"/wiki/High-throughput_sequencing\" class=\"mw-redirect\" title=\"High-throughput sequencing\">high-throughput</a> methods along with DNA <a href=\"/wiki/Copy_number_analysis\" title=\"Copy number analysis\">copy number analysis</a> and <a href=\"/wiki/Karyotyping\" class=\"mw-redirect\" title=\"Karyotyping\">karyotyping</a> should establish the presence of <i>GATA2</i> gene mutations; comparison of detected gene mutations to the list of inactivating GATA2 gene mutations plus the clinical presentation and family history are essentials in making the diagnosis of GATA2 deficiency.<sup id=\"cite_ref-pmid21892158_5-3\" class=\"reference\"><a href=\"#cite_note-pmid21892158-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-pmid25659730_31-0\" class=\"reference\"><a href=\"#cite_note-pmid25659730-31\">&#91;31&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Treatment\">Treatment</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=21\" title=\"Edit section: Treatment\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The various interventions recommended for GATA2 deficiency fall into three categories: family counseling, prevention of the disease's many complications, and bone marrow transplantation in an effort to restore GATA2-sufficient stem cells. However, due to the uncommonness of, and only recent appreciation for, the disease, standard <a href=\"/wiki/Clinical_trial#Phases\" title=\"Clinical trial\">phase 2 clinical trials</a> to establish the efficacy of a drug(s), and/or non-drug treatment regiments against an appropriate <a href=\"/wiki/Placebo\" title=\"Placebo\">placebo</a> treatment regimen have not been reported.\n</p>\n<h3><span class=\"mw-headline\" id=\"Family_counseling\">Family counseling</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=22\" title=\"Edit section: Family counseling\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Family members of an individual(s) diagnosed with an inactivating <i>GATA2</i> gene mutation should be told of their chances of having this mutation, advised of the consequences of this mutation, recommended to be tested for the mutation, warned that they are not suitable donors for any GATA2 deficient individual, and offered long term follow up of their mutation.<sup id=\"cite_ref-pmid28179280_1-12\" class=\"reference\"><a href=\"#cite_note-pmid28179280-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-pmid28643018_2-15\" class=\"reference\"><a href=\"#cite_note-pmid28643018-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-pmid28637621_10-10\" class=\"reference\"><a href=\"#cite_note-pmid28637621-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-pmid25397911_15-5\" class=\"reference\"><a href=\"#cite_note-pmid25397911-15\">&#91;15&#93;</a></sup><sup id=\"cite_ref-pmid25659730_31-1\" class=\"reference\"><a href=\"#cite_note-pmid25659730-31\">&#91;31&#93;</a></sup><sup id=\"cite_ref-pmid29189513_32-0\" class=\"reference\"><a href=\"#cite_note-pmid29189513-32\">&#91;32&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Prevention_of_complications\">Prevention of complications</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=23\" title=\"Edit section: Prevention of complications\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Recommendations for individuals exhibiting susceptibility to the infectious complications of GATA2 deficiency (e.g. MonoMAC-afflicted individuals) include: early vaccination for papillomavirus, early vaccination or prophylaxis drug treatment for nontuberculosus mycobacteria, and, perhaps, prophylaxis drug treatment (e.g. <a href=\"/wiki/Azithromycin\" title=\"Azithromycin\">Azithromycin</a>) for bacteria.<sup id=\"cite_ref-pmid25397911_15-6\" class=\"reference\"><a href=\"#cite_note-pmid25397911-15\">&#91;15&#93;</a></sup><sup id=\"cite_ref-pmid27913495_33-0\" class=\"reference\"><a href=\"#cite_note-pmid27913495-33\">&#91;33&#93;</a></sup> Standard methods are recommended for the <a href=\"/wiki/Deep_vein_thrombosis#Prevention\" title=\"Deep vein thrombosis\">prevention of deep vein thrombosis</a> and/or the <a href=\"/wiki/Embolism\" title=\"Embolism\">embolism</a> that occur in lymphedema of the lower extremities and for the <a href=\"/wiki/Thrombophilia\" title=\"Thrombophilia\">blood hypercoagulability state</a> complicating GATA2 insufficiency presentations such as the Emberger syndrome.<sup id=\"cite_ref-pmid21892158_5-4\" class=\"reference\"><a href=\"#cite_note-pmid21892158-5\">&#91;5&#93;</a></sup> GATA2 deficient individuals should be routinely monitored by: <b>a)</b> frequent <a href=\"/wiki/Complete_blood_count\" title=\"Complete blood count\">complete blood counts</a> and when indicated <a href=\"/wiki/Bone_marrow_examination\" title=\"Bone marrow examination\">bone marrow examinations</a> to detect progression of their disorder to more MDS or leukemia; <b>b)</b> and clinical evaluation of respiratory function and when indicated <a href=\"/wiki/Lung_function_tests\" class=\"mw-redirect\" title=\"Lung function tests\">lung function tests</a> to detect deterioration of lung function,; and <b>c)</b> clinical evaluaton analyses to determine the infection susceptibility, tumor formation, and the worsening function of other organs.<sup id=\"cite_ref-pmid28179280_1-13\" class=\"reference\"><a href=\"#cite_note-pmid28179280-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-pmid28643018_2-16\" class=\"reference\"><a href=\"#cite_note-pmid28643018-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-pmid28637621_10-11\" class=\"reference\"><a href=\"#cite_note-pmid28637621-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-pmid25397911_15-7\" class=\"reference\"><a href=\"#cite_note-pmid25397911-15\">&#91;15&#93;</a></sup><sup id=\"cite_ref-pmid25659730_31-2\" class=\"reference\"><a href=\"#cite_note-pmid25659730-31\">&#91;31&#93;</a></sup><sup id=\"cite_ref-pmid29189513_32-1\" class=\"reference\"><a href=\"#cite_note-pmid29189513-32\">&#91;32&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Bone_marrow_transplantation\">Bone marrow transplantation</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=24\" title=\"Edit section: Bone marrow transplantation\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Many authorities currently recommend GATA2 deficiency be treated by a moderately but not maximally aggressive <a href=\"/wiki/Hematopoietic_stem_cell_transplantation#Conditioning_regimens#Myeloablative\" title=\"Hematopoietic stem cell transplantation\">myeloablative</a> conditioning regimen to remove native bone marrow stem/progenitor cells followed by <a href=\"/wiki/Hematopoietic_stem_cell_transplantation\" title=\"Hematopoietic stem cell transplantation\">hematopoietic stem cell transplantation</a> to repopulate the bone marrow with GATA2 sufficient stem cells.<sup id=\"cite_ref-pmid28179280_1-14\" class=\"reference\"><a href=\"#cite_note-pmid28179280-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-pmid28643018_2-17\" class=\"reference\"><a href=\"#cite_note-pmid28643018-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-pmid28637621_10-12\" class=\"reference\"><a href=\"#cite_note-pmid28637621-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-pmid25397911_15-8\" class=\"reference\"><a href=\"#cite_note-pmid25397911-15\">&#91;15&#93;</a></sup><sup id=\"cite_ref-pmid29189513_32-2\" class=\"reference\"><a href=\"#cite_note-pmid29189513-32\">&#91;32&#93;</a></sup><sup id=\"cite_ref-pmid25659730_31-3\" class=\"reference\"><a href=\"#cite_note-pmid25659730-31\">&#91;31&#93;</a></sup> The use of this procedure should be anticipatory and occur before the development of a hyperellular bone marrow or a bone marrow or blood populated by an excess of <a href=\"/wiki/Progenitor_cells\" class=\"mw-redirect\" title=\"Progenitor cells\">progenitor cells</a> (i.e. blast cells &gt;2% to 5%). These developments are often followed by transformation of the disorder to a leukemia.<sup id=\"cite_ref-pmid29438960_26-2\" class=\"reference\"><a href=\"#cite_note-pmid29438960-26\">&#91;26&#93;</a></sup><sup id=\"cite_ref-pmid28637621_10-13\" class=\"reference\"><a href=\"#cite_note-pmid28637621-10\">&#91;10&#93;</a></sup> This regiment should also be performed before the development of severe systemic infections, tumors, or deterioration in lung function. disease. While it takes up to 3.5 years for this regiment to fully re-institute good immune function, it significantly reduces susceptibility to infections and infection-induced tumor formation.<sup id=\"cite_ref-pmid28637621_10-14\" class=\"reference\"><a href=\"#cite_note-pmid28637621-10\">&#91;10&#93;</a></sup> The regimen also improves or normalizes lung function in cases of pulmonary alveolar proteinosis and pulmonary artery hypertension and may halt the progression or improve the function of other organs directly injured by GATA2 deficiency.<sup id=\"cite_ref-pmid28637621_10-15\" class=\"reference\"><a href=\"#cite_note-pmid28637621-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-pmid25397911_15-9\" class=\"reference\"><a href=\"#cite_note-pmid25397911-15\">&#91;15&#93;</a></sup><sup id=\"cite_ref-pmid25619630_23-4\" class=\"reference\"><a href=\"#cite_note-pmid25619630-23\">&#91;23&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Clinical_trials\">Clinical trials</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=25\" title=\"Edit section: Clinical trials\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>Many reports on the recommended treatment of GATA2 deficiency follow an NIH clinical trial termed \"A Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant regimen for Patients With GATA2 Mutations\". This trial used a regimen of drugs (<a href=\"/wiki/Cyclophosphamide\" title=\"Cyclophosphamide\">cyclophosphamide</a>, <a href=\"/wiki/Fludarabine\" title=\"Fludarabine\">fludarabine</a>) and <a href=\"/wiki/Total_body_irradiation\" title=\"Total body irradiation\">total body irradiation</a> conditioning followed by <a href=\"/wiki/Allogenic\" class=\"mw-redirect\" title=\"Allogenic\">allogenic</a> hematopoietic Stem Cell Transplant on 10 patients. The trial had 8 disease-free survivors and obtained an overall survival 76 months with a range of 18 to 95 months.<sup id=\"cite_ref-34\" class=\"reference\"><a href=\"#cite_note-34\">&#91;34&#93;</a></sup> An NIH intervention study is in the process of recruiting and treating 144 individuals with GATA2 deficiency to determine the success of a treatment regimen consisting of druga (<a href=\"/wiki/Fludarabine\" title=\"Fludarabine\">fludarabine</a>, <a href=\"/wiki/Busulfan\" title=\"Busulfan\">busulfan</a>, <a href=\"/wiki/Cyclophosphamide\" title=\"Cyclophosphamide\">cyclophosphamide</a>) and total body irradiation conditioning followed by allogenic hematopoietic stem cell transplantation.<sup id=\"cite_ref-35\" class=\"reference\"><a href=\"#cite_note-35\">&#91;35&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Prognosis\">Prognosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=26\" title=\"Edit section: Prognosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p><a href=\"/wiki/Survival_rate#Overall_survival\" title=\"Survival rate\">Overall survival</a> in a NIH study using a modest conditioning regimen (see previous section) followed by hematologic stem cell transplantation in GATA2 deficient patients afflicted with immune deficiencies was 54% at 4 years;  GATA2 deficient childrent transplanted for MDS with monosomy 7 experienced a 5 year survival of 68%.<sup id=\"cite_ref-pmid28637621_10-16\" class=\"reference\"><a href=\"#cite_note-pmid28637621-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-pmid28643018_2-18\" class=\"reference\"><a href=\"#cite_note-pmid28643018-2\">&#91;2&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=GATA2_deficiency&amp;action=edit&amp;section=27\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-pmid28179280-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid28179280_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid28179280_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid28179280_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid28179280_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid28179280_1-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-pmid28179280_1-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-pmid28179280_1-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-pmid28179280_1-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-pmid28179280_1-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-pmid28179280_1-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-pmid28179280_1-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-pmid28179280_1-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-pmid28179280_1-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-pmid28179280_1-13\"><sup><i><b>n</b></i></sup></a> <a href=\"#cite_ref-pmid28179280_1-14\"><sup><i><b>o</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Crispino JD, Horwitz MS (April 2017). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5391620\">\"GATA factor mutations in hematologic disease\"</a>. <i>Blood</i>. <b>129</b> (15): 2103\u20132110. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1182/blood-2016-09-687889\">10.1182/blood-2016-09-687889</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5391620\">5391620</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28179280\">28179280</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Blood&amp;rft.atitle=GATA+factor+mutations+in+hematologic+disease&amp;rft.volume=129&amp;rft.issue=15&amp;rft.pages=2103-2110&amp;rft.date=2017-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5391620&amp;rft_id=info%3Apmid%2F28179280&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2016-09-687889&amp;rft.aulast=Crispino&amp;rft.aufirst=JD&amp;rft.au=Horwitz%2C+MS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5391620&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid28643018-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid28643018_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid28643018_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid28643018_2-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid28643018_2-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid28643018_2-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-pmid28643018_2-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-pmid28643018_2-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-pmid28643018_2-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-pmid28643018_2-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-pmid28643018_2-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-pmid28643018_2-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-pmid28643018_2-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-pmid28643018_2-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-pmid28643018_2-13\"><sup><i><b>n</b></i></sup></a> <a href=\"#cite_ref-pmid28643018_2-14\"><sup><i><b>o</b></i></sup></a> <a href=\"#cite_ref-pmid28643018_2-15\"><sup><i><b>p</b></i></sup></a> <a href=\"#cite_ref-pmid28643018_2-16\"><sup><i><b>q</b></i></sup></a> <a href=\"#cite_ref-pmid28643018_2-17\"><sup><i><b>r</b></i></sup></a> <a href=\"#cite_ref-pmid28643018_2-18\"><sup><i><b>s</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hirabayashi S, Wlodarski MW, Kozyra E, Niemeyer CM (August 2017). \"Heterogeneity of GATA2-related myeloid neoplasms\". <i>International Journal of Hematology</i>. <b>106</b> (2): 175\u2013182. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s12185-017-2285-2\">10.1007/s12185-017-2285-2</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28643018\">28643018</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Hematology&amp;rft.atitle=Heterogeneity+of+GATA2-related+myeloid+neoplasms&amp;rft.volume=106&amp;rft.issue=2&amp;rft.pages=175-182&amp;rft.date=2017-08&amp;rft_id=info%3Adoi%2F10.1007%2Fs12185-017-2285-2&amp;rft_id=info%3Apmid%2F28643018&amp;rft.aulast=Hirabayashi&amp;rft.aufirst=S&amp;rft.au=Wlodarski%2C+MW&amp;rft.au=Kozyra%2C+E&amp;rft.au=Niemeyer%2C+CM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid27248996-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid27248996_3-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bannon SA, DiNardo CD (May 2016). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4926372\">\"Hereditary Predispositions to Myelodysplastic Syndrome\"</a>. <i>International Journal of Molecular Sciences</i>. <b>17</b> (6): 838. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3390/ijms17060838\">10.3390/ijms17060838</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4926372\">4926372</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27248996\">27248996</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Molecular+Sciences&amp;rft.atitle=Hereditary+Predispositions+to+Myelodysplastic+Syndrome&amp;rft.volume=17&amp;rft.issue=6&amp;rft.pages=838&amp;rft.date=2016-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4926372&amp;rft_id=info%3Apmid%2F27248996&amp;rft_id=info%3Adoi%2F10.3390%2Fijms17060838&amp;rft.aulast=Bannon&amp;rft.aufirst=SA&amp;rft.au=DiNardo%2C+CD&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4926372&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid24467820-4\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid24467820_4-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid24467820_4-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">West AH, Godley LA, Churpek JE (March 2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3961519\">\"Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations\"</a>. <i>Annals of the New York Academy of Sciences</i>. <b>1310</b>: 111\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/nyas.12346\">10.1111/nyas.12346</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3961519\">3961519</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24467820\">24467820</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+the+New+York+Academy+of+Sciences&amp;rft.atitle=Familial+myelodysplastic+syndrome%2Facute+leukemia+syndromes%3A+a+review+and+utility+for+translational+investigations&amp;rft.volume=1310&amp;rft.pages=111-8&amp;rft.date=2014-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3961519&amp;rft_id=info%3Apmid%2F24467820&amp;rft_id=info%3Adoi%2F10.1111%2Fnyas.12346&amp;rft.aulast=West&amp;rft.aufirst=AH&amp;rft.au=Godley%2C+LA&amp;rft.au=Churpek%2C+JE&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3961519&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid21892158-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid21892158_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid21892158_5-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid21892158_5-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid21892158_5-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid21892158_5-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ostergaard P, Simpson MA, Connell FC, Steward CG, Brice G, Woollard WJ, Dafou D, Kilo T, Smithson S, Lunt P, Murday VA, Hodgson S, Keenan R, Pilz DT, Martinez-Corral I, Makinen T, Mortimer PS, Jeffery S, Trembath RC, Mansour S (September 2011). \"Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)\". <i>Nature Genetics</i>. <b>43</b> (10): 929\u201331. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/ng.923\">10.1038/ng.923</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21892158\">21892158</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Genetics&amp;rft.atitle=Mutations+in+GATA2+cause+primary+lymphedema+associated+with+a+predisposition+to+acute+myeloid+leukemia+%28Emberger+syndrome%29&amp;rft.volume=43&amp;rft.issue=10&amp;rft.pages=929-31&amp;rft.date=2011-09&amp;rft_id=info%3Adoi%2F10.1038%2Fng.923&amp;rft_id=info%3Apmid%2F21892158&amp;rft.aulast=Ostergaard&amp;rft.aufirst=P&amp;rft.au=Simpson%2C+MA&amp;rft.au=Connell%2C+FC&amp;rft.au=Steward%2C+CG&amp;rft.au=Brice%2C+G&amp;rft.au=Woollard%2C+WJ&amp;rft.au=Dafou%2C+D&amp;rft.au=Kilo%2C+T&amp;rft.au=Smithson%2C+S&amp;rft.au=Lunt%2C+P&amp;rft.au=Murday%2C+VA&amp;rft.au=Hodgson%2C+S&amp;rft.au=Keenan%2C+R&amp;rft.au=Pilz%2C+DT&amp;rft.au=Martinez-Corral%2C+I&amp;rft.au=Makinen%2C+T&amp;rft.au=Mortimer%2C+PS&amp;rft.au=Jeffery%2C+S&amp;rft.au=Trembath%2C+RC&amp;rft.au=Mansour%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid21765025-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid21765025_6-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Dickinson RE, Griffin H, Bigley V, Reynard LN, Hussain R, Haniffa M, Lakey JH, Rahman T, Wang XN, McGovern N, Pagan S, Cookson S, McDonald D, Chua I, Wallis J, Cant A, Wright M, Keavney B, Chinnery PF, Loughlin J, Hambleton S, Santibanez-Koref M, Collin M (September 2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5137783\">\"Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency\"</a>. <i>Blood</i>. <b>118</b> (10): 2656\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1182/blood-2011-06-360313\">10.1182/blood-2011-06-360313</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5137783\">5137783</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21765025\">21765025</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Blood&amp;rft.atitle=Exome+sequencing+identifies+GATA-2+mutation+as+the+cause+of+dendritic+cell%2C+monocyte%2C+B+and+NK+lymphoid+deficiency&amp;rft.volume=118&amp;rft.issue=10&amp;rft.pages=2656-8&amp;rft.date=2011-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5137783&amp;rft_id=info%3Apmid%2F21765025&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2011-06-360313&amp;rft.aulast=Dickinson&amp;rft.aufirst=RE&amp;rft.au=Griffin%2C+H&amp;rft.au=Bigley%2C+V&amp;rft.au=Reynard%2C+LN&amp;rft.au=Hussain%2C+R&amp;rft.au=Haniffa%2C+M&amp;rft.au=Lakey%2C+JH&amp;rft.au=Rahman%2C+T&amp;rft.au=Wang%2C+XN&amp;rft.au=McGovern%2C+N&amp;rft.au=Pagan%2C+S&amp;rft.au=Cookson%2C+S&amp;rft.au=McDonald%2C+D&amp;rft.au=Chua%2C+I&amp;rft.au=Wallis%2C+J&amp;rft.au=Cant%2C+A&amp;rft.au=Wright%2C+M&amp;rft.au=Keavney%2C+B&amp;rft.au=Chinnery%2C+PF&amp;rft.au=Loughlin%2C+J&amp;rft.au=Hambleton%2C+S&amp;rft.au=Santibanez-Koref%2C+M&amp;rft.au=Collin%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5137783&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid21892162-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid21892162_7-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hahn CN, Chong CE, Carmichael CL, Wilkins EJ, Brautigan PJ, Li XC, Babic M, Lin M, Carmagnac A, Lee YK, Kok CH, Gagliardi L, Friend KL, Ekert PG, Butcher CM, Brown AL, Lewis ID, To LB, Timms AE, Storek J, Moore S, Altree M, Escher R, Bardy PG, Suthers GK, D'Andrea RJ, Horwitz MS, Scott HS (September 2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3184204\">\"Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia\"</a>. <i>Nature Genetics</i>. <b>43</b> (10): 1012\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/ng.913\">10.1038/ng.913</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3184204\">3184204</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21892162\">21892162</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Genetics&amp;rft.atitle=Heritable+GATA2+mutations+associated+with+familial+myelodysplastic+syndrome+and+acute+myeloid+leukemia&amp;rft.volume=43&amp;rft.issue=10&amp;rft.pages=1012-7&amp;rft.date=2011-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3184204&amp;rft_id=info%3Apmid%2F21892162&amp;rft_id=info%3Adoi%2F10.1038%2Fng.913&amp;rft.aulast=Hahn&amp;rft.aufirst=CN&amp;rft.au=Chong%2C+CE&amp;rft.au=Carmichael%2C+CL&amp;rft.au=Wilkins%2C+EJ&amp;rft.au=Brautigan%2C+PJ&amp;rft.au=Li%2C+XC&amp;rft.au=Babic%2C+M&amp;rft.au=Lin%2C+M&amp;rft.au=Carmagnac%2C+A&amp;rft.au=Lee%2C+YK&amp;rft.au=Kok%2C+CH&amp;rft.au=Gagliardi%2C+L&amp;rft.au=Friend%2C+KL&amp;rft.au=Ekert%2C+PG&amp;rft.au=Butcher%2C+CM&amp;rft.au=Brown%2C+AL&amp;rft.au=Lewis%2C+ID&amp;rft.au=To%2C+LB&amp;rft.au=Timms%2C+AE&amp;rft.au=Storek%2C+J&amp;rft.au=Moore%2C+S&amp;rft.au=Altree%2C+M&amp;rft.au=Escher%2C+R&amp;rft.au=Bardy%2C+PG&amp;rft.au=Suthers%2C+GK&amp;rft.au=D%27Andrea%2C+RJ&amp;rft.au=Horwitz%2C+MS&amp;rft.au=Scott%2C+HS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3184204&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid23048181-8\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid23048181_8-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid23048181_8-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chlon TM, Crispino JD (November 2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3472596\">\"Combinatorial regulation of tissue specification by GATA and FOG factors\"</a>. <i>Development</i>. <b>139</b> (21): 3905\u201316. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1242/dev.080440\">10.1242/dev.080440</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3472596\">3472596</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23048181\">23048181</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Development&amp;rft.atitle=Combinatorial+regulation+of+tissue+specification+by+GATA+and+FOG+factors&amp;rft.volume=139&amp;rft.issue=21&amp;rft.pages=3905-16&amp;rft.date=2012-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3472596&amp;rft_id=info%3Apmid%2F23048181&amp;rft_id=info%3Adoi%2F10.1242%2Fdev.080440&amp;rft.aulast=Chlon&amp;rft.aufirst=TM&amp;rft.au=Crispino%2C+JD&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3472596&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"https://www.ncbi.nlm.nih.gov/gene/2624\">https://www.ncbi.nlm.nih.gov/gene/2624</a></span>\n</li>\n<li id=\"cite_note-pmid28637621-10\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid28637621_10-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid28637621_10-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid28637621_10-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid28637621_10-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid28637621_10-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-pmid28637621_10-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-pmid28637621_10-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-pmid28637621_10-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-pmid28637621_10-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-pmid28637621_10-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-pmid28637621_10-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-pmid28637621_10-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-pmid28637621_10-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-pmid28637621_10-13\"><sup><i><b>n</b></i></sup></a> <a href=\"#cite_ref-pmid28637621_10-14\"><sup><i><b>o</b></i></sup></a> <a href=\"#cite_ref-pmid28637621_10-15\"><sup><i><b>p</b></i></sup></a> <a href=\"#cite_ref-pmid28637621_10-16\"><sup><i><b>q</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wlodarski MW, Collin M, Horwitz MS (April 2017). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5650112\">\"GATA2 deficiency and related myeloid neoplasms\"</a>. <i>Seminars in Hematology</i>. <b>54</b> (2): 81\u201386. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1053/j.seminhematol.2017.05.002\">10.1053/j.seminhematol.2017.05.002</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5650112\">5650112</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28637621\">28637621</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Seminars+in+Hematology&amp;rft.atitle=GATA2+deficiency+and+related+myeloid+neoplasms&amp;rft.volume=54&amp;rft.issue=2&amp;rft.pages=81-86&amp;rft.date=2017-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5650112&amp;rft_id=info%3Apmid%2F28637621&amp;rft_id=info%3Adoi%2F10.1053%2Fj.seminhematol.2017.05.002&amp;rft.aulast=Wlodarski&amp;rft.aufirst=MW&amp;rft.au=Collin%2C+M&amp;rft.au=Horwitz%2C+MS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5650112&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid28179282-11\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid28179282_11-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid28179282_11-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid28179282_11-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid28179282_11-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid28179282_11-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-pmid28179282_11-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-pmid28179282_11-6\"><sup><i><b>g</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Katsumura KR, Bresnick EH (April 2017). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5391619\">\"The GATA factor revolution in hematology\"</a>. <i>Blood</i>. <b>129</b> (15): 2092\u20132102. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1182/blood-2016-09-687871\">10.1182/blood-2016-09-687871</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5391619\">5391619</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28179282\">28179282</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Blood&amp;rft.atitle=The+GATA+factor+revolution+in+hematology&amp;rft.volume=129&amp;rft.issue=15&amp;rft.pages=2092-2102&amp;rft.date=2017-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5391619&amp;rft_id=info%3Apmid%2F28179282&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2016-09-687871&amp;rft.aulast=Katsumura&amp;rft.aufirst=KR&amp;rft.au=Bresnick%2C+EH&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5391619&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid27235756-12\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid27235756_12-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid27235756_12-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Shimizu R, Yamamoto M (August 2016). \"GATA-related hematologic disorders\". <i>Experimental Hematology</i>. <b>44</b> (8): 696\u2013705. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.exphem.2016.05.010\">10.1016/j.exphem.2016.05.010</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27235756\">27235756</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Experimental+Hematology&amp;rft.atitle=GATA-related+hematologic+disorders&amp;rft.volume=44&amp;rft.issue=8&amp;rft.pages=696-705&amp;rft.date=2016-08&amp;rft_id=info%3Adoi%2F10.1016%2Fj.exphem.2016.05.010&amp;rft_id=info%3Apmid%2F27235756&amp;rft.aulast=Shimizu&amp;rft.aufirst=R&amp;rft.au=Yamamoto%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid24227816-13\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid24227816_13-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid24227816_13-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid24227816_13-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid24227816_13-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid24227816_13-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-pmid24227816_13-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-pmid24227816_13-6\"><sup><i><b>g</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR, Arthur DC, Gu W, Gould CM, Brewer CC, Cowen EW, Freeman AF, Olivier KN, Uzel G, Zelazny AM, Daub JR, Spalding CD, Claypool RJ, Giri NK, Alter BP, Mace EM, Orange JS, Cuellar-Rodriguez J, Hickstein DD, Holland SM (February 2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3916876\">\"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity\"</a>. <i>Blood</i>. <b>123</b> (6): 809\u201321. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1182/blood-2013-07-515528\">10.1182/blood-2013-07-515528</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3916876\">3916876</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24227816\">24227816</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Blood&amp;rft.atitle=GATA2+deficiency%3A+a+protean+disorder+of+hematopoiesis%2C+lymphatics%2C+and+immunity&amp;rft.volume=123&amp;rft.issue=6&amp;rft.pages=809-21&amp;rft.date=2014-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3916876&amp;rft_id=info%3Apmid%2F24227816&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2013-07-515528&amp;rft.aulast=Spinner&amp;rft.aufirst=MA&amp;rft.au=Sanchez%2C+LA&amp;rft.au=Hsu%2C+AP&amp;rft.au=Shaw%2C+PA&amp;rft.au=Zerbe%2C+CS&amp;rft.au=Calvo%2C+KR&amp;rft.au=Arthur%2C+DC&amp;rft.au=Gu%2C+W&amp;rft.au=Gould%2C+CM&amp;rft.au=Brewer%2C+CC&amp;rft.au=Cowen%2C+EW&amp;rft.au=Freeman%2C+AF&amp;rft.au=Olivier%2C+KN&amp;rft.au=Uzel%2C+G&amp;rft.au=Zelazny%2C+AM&amp;rft.au=Daub%2C+JR&amp;rft.au=Spalding%2C+CD&amp;rft.au=Claypool%2C+RJ&amp;rft.au=Giri%2C+NK&amp;rft.au=Alter%2C+BP&amp;rft.au=Mace%2C+EM&amp;rft.au=Orange%2C+JS&amp;rft.au=Cuellar-Rodriguez%2C+J&amp;rft.au=Hickstein%2C+DD&amp;rft.au=Holland%2C+SM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3916876&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid29452225-14\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid29452225_14-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid29452225_14-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid29452225_14-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid29452225_14-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bigley V, Cytlak U, Collin M (February 2018). \"Human dendritic cell immunodeficiencies\". <i>Seminars in Cell &amp; Developmental Biology</i>. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.semcdb.2018.02.020\">10.1016/j.semcdb.2018.02.020</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29452225\">29452225</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Seminars+in+Cell+%26+Developmental+Biology&amp;rft.atitle=Human+dendritic+cell+immunodeficiencies&amp;rft.date=2018-02&amp;rft_id=info%3Adoi%2F10.1016%2Fj.semcdb.2018.02.020&amp;rft_id=info%3Apmid%2F29452225&amp;rft.aulast=Bigley&amp;rft.aufirst=V&amp;rft.au=Cytlak%2C+U&amp;rft.au=Collin%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid25397911-15\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid25397911_15-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid25397911_15-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid25397911_15-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid25397911_15-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid25397911_15-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-pmid25397911_15-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-pmid25397911_15-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-pmid25397911_15-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-pmid25397911_15-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-pmid25397911_15-9\"><sup><i><b>j</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hsu AP, McReynolds LJ, Holland SM (February 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4342850\">\"GATA2 deficiency\"</a>. <i>Current Opinion in Allergy and Clinical Immunology</i>. <b>15</b> (1): 104\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/ACI.0000000000000126\">10.1097/ACI.0000000000000126</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4342850\">4342850</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25397911\">25397911</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Allergy+and+Clinical+Immunology&amp;rft.atitle=GATA2+deficiency&amp;rft.volume=15&amp;rft.issue=1&amp;rft.pages=104-9&amp;rft.date=2015-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4342850&amp;rft_id=info%3Apmid%2F25397911&amp;rft_id=info%3Adoi%2F10.1097%2FACI.0000000000000126&amp;rft.aulast=Hsu&amp;rft.aufirst=AP&amp;rft.au=McReynolds%2C+LJ&amp;rft.au=Holland%2C+SM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4342850&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid23736028-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid23736028_16-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Katoh M (July 2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3721406\">\"Functional and cancer genomics of ASXL family members\"</a>. <i>British Journal of Cancer</i>. <b>109</b> (2): 299\u2013306. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/bjc.2013.281\">10.1038/bjc.2013.281</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3721406\">3721406</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23736028\">23736028</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Cancer&amp;rft.atitle=Functional+and+cancer+genomics+of+ASXL+family+members&amp;rft.volume=109&amp;rft.issue=2&amp;rft.pages=299-306&amp;rft.date=2013-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3721406&amp;rft_id=info%3Apmid%2F23736028&amp;rft_id=info%3Adoi%2F10.1038%2Fbjc.2013.281&amp;rft.aulast=Katoh&amp;rft.aufirst=M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3721406&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid26017341-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid26017341_17-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wang L, Du F, Zhang HM, Wang HX (July 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4512095\">\"Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literature\"</a>. <i>Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas</i>. <b>48</b> (7): 583\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1590/1414-431X20154557\">10.1590/1414-431X20154557</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4512095\">4512095</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26017341\">26017341</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brazilian+Journal+of+Medical+and+Biological+Research+%3D+Revista+Brasileira+De+Pesquisas+Medicas+E+Biologicas&amp;rft.atitle=Evaluation+of+a+father+and+son+with+atypical+chronic+myeloid+leukemia+with+SETBP1+mutations+and+a+review+of+the+literature&amp;rft.volume=48&amp;rft.issue=7&amp;rft.pages=583-7&amp;rft.date=2015-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4512095&amp;rft_id=info%3Apmid%2F26017341&amp;rft_id=info%3Adoi%2F10.1590%2F1414-431X20154557&amp;rft.aulast=Wang&amp;rft.aufirst=L&amp;rft.au=Du%2C+F&amp;rft.au=Zhang%2C+HM&amp;rft.au=Wang%2C+HX&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4512095&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid29278534-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid29278534_18-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Viny AD, Levine RL (March 2018). \"Cohesin mutations in myeloid malignancies made simple\". <i>Current Opinion in Hematology</i>. <b>25</b> (2): 61\u201366. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/MOH.0000000000000405\">10.1097/MOH.0000000000000405</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29278534\">29278534</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Hematology&amp;rft.atitle=Cohesin+mutations+in+myeloid+malignancies+made+simple&amp;rft.volume=25&amp;rft.issue=2&amp;rft.pages=61-66&amp;rft.date=2018-03&amp;rft_id=info%3Adoi%2F10.1097%2FMOH.0000000000000405&amp;rft_id=info%3Apmid%2F29278534&amp;rft.aulast=Viny&amp;rft.aufirst=AD&amp;rft.au=Levine%2C+RL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid20803646-19\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid20803646_19-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid20803646_19-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid20803646_19-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mansour S, Connell F, Steward C, Ostergaard P, Brice G, Smithson S, Lunt P, Jeffery S, Dokal I, Vulliamy T, Gibson B, Hodgson S, Cottrell S, Kiely L, Tinworth L, Kalidas K, Mufti G, Cornish J, Keenan R, Mortimer P, Murday V (September 2010). \"Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases\". <i>American Journal of Medical Genetics. Part A</i>. <b>152A</b> (9): 2287\u201396. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/ajmg.a.33445\">10.1002/ajmg.a.33445</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20803646\">20803646</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Medical+Genetics.+Part+A&amp;rft.atitle=Emberger+syndrome-primary+lymphedema+with+myelodysplasia%3A+report+of+seven+new+cases&amp;rft.volume=152A&amp;rft.issue=9&amp;rft.pages=2287-96&amp;rft.date=2010-09&amp;rft_id=info%3Adoi%2F10.1002%2Fajmg.a.33445&amp;rft_id=info%3Apmid%2F20803646&amp;rft.aulast=Mansour&amp;rft.aufirst=S&amp;rft.au=Connell%2C+F&amp;rft.au=Steward%2C+C&amp;rft.au=Ostergaard%2C+P&amp;rft.au=Brice%2C+G&amp;rft.au=Smithson%2C+S&amp;rft.au=Lunt%2C+P&amp;rft.au=Jeffery%2C+S&amp;rft.au=Dokal%2C+I&amp;rft.au=Vulliamy%2C+T&amp;rft.au=Gibson%2C+B&amp;rft.au=Hodgson%2C+S&amp;rft.au=Cottrell%2C+S&amp;rft.au=Kiely%2C+L&amp;rft.au=Tinworth%2C+L&amp;rft.au=Kalidas%2C+K&amp;rft.au=Mufti%2C+G&amp;rft.au=Cornish%2C+J&amp;rft.au=Keenan%2C+R&amp;rft.au=Mortimer%2C+P&amp;rft.au=Murday%2C+V&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid28271814-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid28271814_20-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Brambila-Tapia AJ, Garc\u00eda-Ortiz JE, Brouillard P, Nguyen HL, Vikkula M, R\u00edos-Gonz\u00e1lez BE, Sandoval-Mu\u00f1iz RJ, Sandoval-Talamantes AK, Bobadilla-Morales L, Corona-Rivera JR, Arnaud-Lopez L (September 2017). \"GATA2 null mutation associated with incomplete penetrance in a family with Emberger syndrome\". <i>Hematology (Amsterdam, Netherlands)</i>. <b>22</b> (8): 467\u2013471. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1080/10245332.2017.1294551\">10.1080/10245332.2017.1294551</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28271814\">28271814</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hematology+%28Amsterdam%2C+Netherlands%29&amp;rft.atitle=GATA2+null+mutation+associated+with+incomplete+penetrance+in+a+family+with+Emberger+syndrome&amp;rft.volume=22&amp;rft.issue=8&amp;rft.pages=467-471&amp;rft.date=2017-09&amp;rft_id=info%3Adoi%2F10.1080%2F10245332.2017.1294551&amp;rft_id=info%3Apmid%2F28271814&amp;rft.aulast=Brambila-Tapia&amp;rft.aufirst=AJ&amp;rft.au=Garc%C3%ADa-Ortiz%2C+JE&amp;rft.au=Brouillard%2C+P&amp;rft.au=Nguyen%2C+HL&amp;rft.au=Vikkula%2C+M&amp;rft.au=R%C3%ADos-Gonz%C3%A1lez%2C+BE&amp;rft.au=Sandoval-Mu%C3%B1iz%2C+RJ&amp;rft.au=Sandoval-Talamantes%2C+AK&amp;rft.au=Bobadilla-Morales%2C+L&amp;rft.au=Corona-Rivera%2C+JR&amp;rft.au=Arnaud-Lopez%2C+L&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid23728141-21\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid23728141_21-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid23728141_21-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid23728141_21-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Camargo JF, Lobo SA, Hsu AP, Zerbe CS, Wormser GP, Holland SM (September 2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3739466\">\"MonoMAC syndrome in a patient with a GATA2 mutation: case report and review of the literature\"</a>. <i>Clinical Infectious Diseases</i>. <b>57</b> (5): 697\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/cid/cit368\">10.1093/cid/cit368</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3739466\">3739466</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23728141\">23728141</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Infectious+Diseases&amp;rft.atitle=MonoMAC+syndrome+in+a+patient+with+a+GATA2+mutation%3A+case+report+and+review+of+the+literature&amp;rft.volume=57&amp;rft.issue=5&amp;rft.pages=697-9&amp;rft.date=2013-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3739466&amp;rft_id=info%3Apmid%2F23728141&amp;rft_id=info%3Adoi%2F10.1093%2Fcid%2Fcit368&amp;rft.aulast=Camargo&amp;rft.aufirst=JF&amp;rft.au=Lobo%2C+SA&amp;rft.au=Hsu%2C+AP&amp;rft.au=Zerbe%2C+CS&amp;rft.au=Wormser%2C+GP&amp;rft.au=Holland%2C+SM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3739466&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid25739845-22\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid25739845_22-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid25739845_22-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Johnson JA, Yu SS, Elist M, Arkfeld D, Panush RS (September 2015). \"Rheumatologic manifestations of the \"MonoMAC\" syndrome. a systematic review\". <i>Clinical Rheumatology</i>. <b>34</b> (9): 1643\u20135. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s10067-015-2905-2\">10.1007/s10067-015-2905-2</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25739845\">25739845</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Rheumatology&amp;rft.atitle=Rheumatologic+manifestations+of+the+%22MonoMAC%22+syndrome.+a+systematic+review&amp;rft.volume=34&amp;rft.issue=9&amp;rft.pages=1643-5&amp;rft.date=2015-09&amp;rft_id=info%3Adoi%2F10.1007%2Fs10067-015-2905-2&amp;rft_id=info%3Apmid%2F25739845&amp;rft.aulast=Johnson&amp;rft.aufirst=JA&amp;rft.au=Yu%2C+SS&amp;rft.au=Elist%2C+M&amp;rft.au=Arkfeld%2C+D&amp;rft.au=Panush%2C+RS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid25619630-23\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid25619630_23-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid25619630_23-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid25619630_23-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid25619630_23-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid25619630_23-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mir MA, Kochuparambil ST, Abraham RS, Rodriguez V, Howard M, Hsu AP, Jackson AE, Holland SM, Patnaik MM (April 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4402062\">\"Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations\"</a>. <i>Cancer Medicine</i>. <b>4</b> (4): 490\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/cam4.384\">10.1002/cam4.384</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4402062\">4402062</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25619630\">25619630</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Medicine&amp;rft.atitle=Spectrum+of+myeloid+neoplasms+and+immune+deficiency+associated+with+germline+GATA2+mutations&amp;rft.volume=4&amp;rft.issue=4&amp;rft.pages=490-9&amp;rft.date=2015-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4402062&amp;rft_id=info%3Apmid%2F25619630&amp;rft_id=info%3Adoi%2F10.1002%2Fcam4.384&amp;rft.aulast=Mir&amp;rft.aufirst=MA&amp;rft.au=Kochuparambil%2C+ST&amp;rft.au=Abraham%2C+RS&amp;rft.au=Rodriguez%2C+V&amp;rft.au=Howard%2C+M&amp;rft.au=Hsu%2C+AP&amp;rft.au=Jackson%2C+AE&amp;rft.au=Holland%2C+SM&amp;rft.au=Patnaik%2C+MM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4402062&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid21242295-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid21242295_24-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bigley V, Haniffa M, Doulatov S, Wang XN, Dickinson R, McGovern N, Jardine L, Pagan S, Dimmick I, Chua I, Wallis J, Lordan J, Morgan C, Kumararatne DS, Doffinger R, van der Burg M, van Dongen J, Cant A, Dick JE, Hambleton S, Collin M (February 2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3039861\">\"The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency\"</a>. <i>The Journal of Experimental Medicine</i>. <b>208</b> (2): 227\u201334. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1084/jem.20101459\">10.1084/jem.20101459</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3039861\">3039861</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21242295\">21242295</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Experimental+Medicine&amp;rft.atitle=The+human+syndrome+of+dendritic+cell%2C+monocyte%2C+B+and+NK+lymphoid+deficiency&amp;rft.volume=208&amp;rft.issue=2&amp;rft.pages=227-34&amp;rft.date=2011-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3039861&amp;rft_id=info%3Apmid%2F21242295&amp;rft_id=info%3Adoi%2F10.1084%2Fjem.20101459&amp;rft.aulast=Bigley&amp;rft.aufirst=V&amp;rft.au=Haniffa%2C+M&amp;rft.au=Doulatov%2C+S&amp;rft.au=Wang%2C+XN&amp;rft.au=Dickinson%2C+R&amp;rft.au=McGovern%2C+N&amp;rft.au=Jardine%2C+L&amp;rft.au=Pagan%2C+S&amp;rft.au=Dimmick%2C+I&amp;rft.au=Chua%2C+I&amp;rft.au=Wallis%2C+J&amp;rft.au=Lordan%2C+J&amp;rft.au=Morgan%2C+C&amp;rft.au=Kumararatne%2C+DS&amp;rft.au=Doffinger%2C+R&amp;rft.au=van+der+Burg%2C+M&amp;rft.au=van+Dongen%2C+J&amp;rft.au=Cant%2C+A&amp;rft.au=Dick%2C+JE&amp;rft.au=Hambleton%2C+S&amp;rft.au=Collin%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3039861&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid24638828-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid24638828_25-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Moriguchi T, Yamamoto M (November 2014). \"A regulatory network governing Gata1 and Gata2 gene transcription orchestrates erythroid lineage differentiation\". <i>International Journal of Hematology</i>. <b>100</b> (5): 417\u201324. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s12185-014-1568-0\">10.1007/s12185-014-1568-0</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24638828\">24638828</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Hematology&amp;rft.atitle=A+regulatory+network+governing+Gata1+and+Gata2+gene+transcription+orchestrates+erythroid+lineage+differentiation&amp;rft.volume=100&amp;rft.issue=5&amp;rft.pages=417-24&amp;rft.date=2014-11&amp;rft_id=info%3Adoi%2F10.1007%2Fs12185-014-1568-0&amp;rft_id=info%3Apmid%2F24638828&amp;rft.aulast=Moriguchi&amp;rft.aufirst=T&amp;rft.au=Yamamoto%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid29438960-26\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid29438960_26-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid29438960_26-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid29438960_26-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Locatelli F, Strahm B (March 2018). \"How I treat myelodysplastic syndromes of childhood\". <i>Blood</i>. <b>131</b> (13): 1406\u20131414. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1182/blood-2017-09-765214\">10.1182/blood-2017-09-765214</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29438960\">29438960</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Blood&amp;rft.atitle=How+I+treat+myelodysplastic+syndromes+of+childhood&amp;rft.volume=131&amp;rft.issue=13&amp;rft.pages=1406-1414&amp;rft.date=2018-03&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2017-09-765214&amp;rft_id=info%3Apmid%2F29438960&amp;rft.aulast=Locatelli&amp;rft.aufirst=F&amp;rft.au=Strahm%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid27913534-27\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid27913534_27-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid27913534_27-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid27913534_27-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid27913534_27-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-pmid27913534_27-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hasle H (December 2016). \"Myelodysplastic and myeloproliferative disorders of childhood\". <i>Hematology. American Society of Hematology. Education Program</i>. <b>2016</b> (1): 598\u2013604. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1182/asheducation-2016.1.598\">10.1182/asheducation-2016.1.598</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27913534\">27913534</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hematology.+American+Society+of+Hematology.+Education+Program&amp;rft.atitle=Myelodysplastic+and+myeloproliferative+disorders+of+childhood&amp;rft.volume=2016&amp;rft.issue=1&amp;rft.pages=598-604&amp;rft.date=2016-12&amp;rft_id=info%3Adoi%2F10.1182%2Fasheducation-2016.1.598&amp;rft_id=info%3Apmid%2F27913534&amp;rft.aulast=Hasle&amp;rft.aufirst=H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid29156196-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid29156196_28-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Churpek JE (December 2017). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5774636\">\"Familial myelodysplastic syndrome/acute myeloid leukemia\"</a>. <i>Best Practice &amp; Research. Clinical Haematology</i>. <b>30</b> (4): 287\u2013289. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.beha.2017.10.002\">10.1016/j.beha.2017.10.002</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5774636\">5774636</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29156196\">29156196</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Best+Practice+%26+Research.+Clinical+Haematology&amp;rft.atitle=Familial+myelodysplastic+syndrome%2Facute+myeloid+leukemia&amp;rft.volume=30&amp;rft.issue=4&amp;rft.pages=287-289&amp;rft.date=2017-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5774636&amp;rft_id=info%3Apmid%2F29156196&amp;rft_id=info%3Adoi%2F10.1016%2Fj.beha.2017.10.002&amp;rft.aulast=Churpek&amp;rft.aufirst=JE&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5774636&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid28875503-29\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid28875503_29-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid28875503_29-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Donadieu J, Beaupain B, Fenneteau O, Bellann\u00e9-Chantelot C (November 2017). \"Congenital neutropenia in the era of genomics: classification, diagnosis, and natural history\". <i>British Journal of Haematology</i>. <b>179</b> (4): 557\u2013574. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/bjh.14887\">10.1111/bjh.14887</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28875503\">28875503</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Haematology&amp;rft.atitle=Congenital+neutropenia+in+the+era+of+genomics%3A+classification%2C+diagnosis%2C+and+natural+history&amp;rft.volume=179&amp;rft.issue=4&amp;rft.pages=557-574&amp;rft.date=2017-11&amp;rft_id=info%3Adoi%2F10.1111%2Fbjh.14887&amp;rft_id=info%3Apmid%2F28875503&amp;rft.aulast=Donadieu&amp;rft.aufirst=J&amp;rft.au=Beaupain%2C+B&amp;rft.au=Fenneteau%2C+O&amp;rft.au=Bellann%C3%A9-Chantelot%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid29296959-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid29296959_30-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fisher KE, Hsu AP, Williams CL, Sayeed H, Merritt BY, Elghetany MT, Holland SM, Bertuch AA, Gramatges MM (February 2017). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5738979\">\"Somatic mutations in children with GATA2-associated myelodysplastic syndrome who lack other features of GATA2 deficiency\"</a>. <i>Blood Advances</i>. <b>1</b> (7): 443\u2013448. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1182/bloodadvances.2016002311\">10.1182/bloodadvances.2016002311</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5738979\">5738979</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29296959\">29296959</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Blood+Advances&amp;rft.atitle=Somatic+mutations+in+children+with+GATA2-associated+myelodysplastic+syndrome+who+lack+other+features+of+GATA2+deficiency&amp;rft.volume=1&amp;rft.issue=7&amp;rft.pages=443-448&amp;rft.date=2017-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5738979&amp;rft_id=info%3Apmid%2F29296959&amp;rft_id=info%3Adoi%2F10.1182%2Fbloodadvances.2016002311&amp;rft.aulast=Fisher&amp;rft.aufirst=KE&amp;rft.au=Hsu%2C+AP&amp;rft.au=Williams%2C+CL&amp;rft.au=Sayeed%2C+H&amp;rft.au=Merritt%2C+BY&amp;rft.au=Elghetany%2C+MT&amp;rft.au=Holland%2C+SM&amp;rft.au=Bertuch%2C+AA&amp;rft.au=Gramatges%2C+MM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5738979&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid25659730-31\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid25659730_31-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid25659730_31-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid25659730_31-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid25659730_31-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Babushok DV, Bessler M (March 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4323616\">\"Genetic predisposition syndromes: when should they be considered in the work-up of MDS?\"</a>. <i>Best Practice &amp; Research. Clinical Haematology</i>. <b>28</b> (1): 55\u201368. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.beha.2014.11.004\">10.1016/j.beha.2014.11.004</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4323616\">4323616</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25659730\">25659730</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Best+Practice+%26+Research.+Clinical+Haematology&amp;rft.atitle=Genetic+predisposition+syndromes%3A+when+should+they+be+considered+in+the+work-up+of+MDS%3F&amp;rft.volume=28&amp;rft.issue=1&amp;rft.pages=55-68&amp;rft.date=2015-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4323616&amp;rft_id=info%3Apmid%2F25659730&amp;rft_id=info%3Adoi%2F10.1016%2Fj.beha.2014.11.004&amp;rft.aulast=Babushok&amp;rft.aufirst=DV&amp;rft.au=Bessler%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4323616&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid29189513-32\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid29189513_32-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid29189513_32-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid29189513_32-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rastogi N, Abraham RS, Chadha R, Thakkar D, Kohli S, Nivargi S, Prakash Yadav S (November 2017). \"Successful Nonmyeloablative Allogeneic Stem Cell Transplant in a Child With Emberger Syndrome and GATA2 Mutation\". <i>Journal of Pediatric Hematology/oncology</i>: 1. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/MPH.0000000000000995\">10.1097/MPH.0000000000000995</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29189513\">29189513</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Pediatric+Hematology%2Foncology&amp;rft.atitle=Successful+Nonmyeloablative+Allogeneic+Stem+Cell+Transplant+in+a+Child+With+Emberger+Syndrome+and+GATA2+Mutation&amp;rft.pages=1&amp;rft.date=2017-11&amp;rft_id=info%3Adoi%2F10.1097%2FMPH.0000000000000995&amp;rft_id=info%3Apmid%2F29189513&amp;rft.aulast=Rastogi&amp;rft.aufirst=N&amp;rft.au=Abraham%2C+RS&amp;rft.au=Chadha%2C+R&amp;rft.au=Thakkar%2C+D&amp;rft.au=Kohli%2C+S&amp;rft.au=Nivargi%2C+S&amp;rft.au=Prakash+Yadav%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid27913495-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid27913495_33-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Porter CC (December 2016). \"Germ line mutations associated with leukemias\". <i>Hematology. American Society of Hematology. Education Program</i>. <b>2016</b> (1): 302\u2013308. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1182/asheducation-2016.1.302\">10.1182/asheducation-2016.1.302</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27913495\">27913495</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hematology.+American+Society+of+Hematology.+Education+Program&amp;rft.atitle=Germ+line+mutations+associated+with+leukemias&amp;rft.volume=2016&amp;rft.issue=1&amp;rft.pages=302-308&amp;rft.date=2016-12&amp;rft_id=info%3Adoi%2F10.1182%2Fasheducation-2016.1.302&amp;rft_id=info%3Apmid%2F27913495&amp;rft.aulast=Porter&amp;rft.aufirst=CC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGATA2+deficiency\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-34\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"https://clinicaltrials.gov/ct2/show/results/NCT00923364?cond=GATA2+deficiency&amp;rank=3&amp;sect=X01256#all\">https://clinicaltrials.gov/ct2/show/results/NCT00923364?cond=GATA2+deficiency&amp;rank=3&amp;sect=X01256#all</a></span>\n</li>\n<li id=\"cite_note-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-35\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"https://clinicaltrials.gov/ct2/show/NCT01861106?term=NCT01861106&amp;rank=1\">https://clinicaltrials.gov/ct2/show/NCT01861106?term=NCT01861106&amp;rank=1</a></span>\n</li>\n</ol></div></div>\n\n<!-- \nNewPP limit report\nParsed by mw2180\nCached time: 20180915185705\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.540 seconds\nReal time usage: 0.571 seconds\nPreprocessor visited node count: 2370/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 86648/2097152 bytes\nTemplate argument size: 80/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 84492/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.245/10.000 seconds\nLua memory usage: 3.37 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  392.499      1 -total\n 84.89%  333.206      1 Template:Reflist\n 65.37%  256.585     32 Template:Cite_journal\n  6.89%   27.027      9 Template:Main\n  0.84%    3.299      1 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:57618746-0!canonical and timestamp 20180915185704 and revision id 847386101\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","*":"Syndromes"},{"sortkey":"","*":"Autosomal_dominant_disorders"},{"sortkey":"","*":"Transcription_factor_deficiencies"},{"sortkey":"","*":"Leukemia"},{"sortkey":"","*":"Immunodeficiency"},{"sortkey":"","*":"Immune_system_disorders"}],"links":[{"ns":0,"exists":"","*":"ASXL1"},{"ns":0,"exists":"","*":"Acute myeloid leukemia"},{"ns":0,"exists":"","*":"Adaptive immune system"},{"ns":0,"exists":"","*":"Allogenic"},{"ns":0,"exists":"","*":"Aplastic anemia"},{"ns":0,"exists":"","*":"Arthralgia"},{"ns":0,"exists":"","*":"Arthritis"},{"ns":0,"exists":"","*":"Aspergillus"},{"ns":0,"exists":"","*":"Asymptomatic"},{"ns":0,"exists":"","*":"Autism spectrum"},{"ns":0,"exists":"","*":"Autoimmune disease"},{"ns":0,"exists":"","*":"Autoimmunity"},{"ns":0,"exists":"","*":"Autoregulation"},{"ns":0,"exists":"","*":"Autosomal dominant"},{"ns":0,"exists":"","*":"Azithromycin"},{"ns":0,"exists":"","*":"B cell"},{"ns":0,"exists":"","*":"B cells"},{"ns":0,"exists":"","*":"B lymphocyte"},{"ns":0,"exists":"","*":"Base pair"},{"ns":0,"exists":"","*":"Blast cell"},{"ns":0,"exists":"","*":"Blood"},{"ns":0,"exists":"","*":"Body dysmorphic disorder"},{"ns":0,"exists":"","*":"Bone marrow biopsy"},{"ns":0,"exists":"","*":"Bone marrow examination"},{"ns":0,"exists":"","*":"Bone marrow failure"},{"ns":0,"exists":"","*":"Bowen disease"},{"ns":0,"exists":"","*":"Bowenoid papulosis"},{"ns":0,"exists":"","*":"Breast cancer"},{"ns":0,"exists":"","*":"Busulfan"},{"ns":0,"exists":"","*":"C-terminus"},{"ns":0,"exists":"","*":"CXCL2"},{"ns":0,"exists":"","*":"Candida (fungus)"},{"ns":0,"exists":"","*":"Case report"},{"ns":0,"exists":"","*":"Cell nucleus"},{"ns":0,"exists":"","*":"Cellular differentiation"},{"ns":0,"exists":"","*":"Cellulitis"},{"ns":0,"exists":"","*":"Central nervous system"},{"ns":0,"exists":"","*":"Cervical carcinoma"},{"ns":0,"exists":"","*":"Chromosome 3"},{"ns":0,"exists":"","*":"Chromosome 7"},{"ns":0,"exists":"","*":"Chronic headache"},{"ns":0,"exists":"","*":"Chronic lymphocytic leukemia"},{"ns":0,"exists":"","*":"Chronic myelogenous leukemia"},{"ns":0,"exists":"","*":"Chronic myelomonocytic leukemia"},{"ns":0,"exists":"","*":"Chronic neutropenia"},{"ns":0,"exists":"","*":"Chronic neutrophilic leukemia"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Coding region"},{"ns":0,"exists":"","*":"Complete blood count"},{"ns":0,"exists":"","*":"Copy number analysis"},{"ns":0,"exists":"","*":"Cripto"},{"ns":0,"exists":"","*":"Cryptogenic organizing pneumonia"},{"ns":0,"exists":"","*":"Cyclophosphamide"},{"ns":0,"exists":"","*":"Cytomegalovirus"},{"ns":0,"exists":"","*":"Cytoplasm"},{"ns":0,"exists":"","*":"DNA"},{"ns":0,"exists":"","*":"DNA methylation"},{"ns":0,"exists":"","*":"DNA sequencing"},{"ns":0,"exists":"","*":"Deep vein thrombosis"},{"ns":0,"exists":"","*":"Deletion (genetics)"},{"ns":0,"exists":"","*":"Dendritic cells"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Directionality (molecular biology)"},{"ns":0,"exists":"","*":"Dysplasia"},{"ns":0,"exists":"","*":"Emberger syndrome"},{"ns":0,"exists":"","*":"Embolism"},{"ns":0,"exists":"","*":"Embryogenesis"},{"ns":0,"exists":"","*":"Emotional and behavioral disorders"},{"ns":0,"exists":"","*":"Endocarditis"},{"ns":0,"exists":"","*":"Endothelium"},{"ns":0,"exists":"","*":"Enhancer (genetics)"},{"ns":0,"exists":"","*":"Epicanthic folds"},{"ns":0,"exists":"","*":"Epstein-Barr virus"},{"ns":0,"exists":"","*":"Epstein-Barr virus infection"},{"ns":0,"exists":"","*":"Epstein\u2013Barr virus infection"},{"ns":0,"exists":"","*":"Erythema nodosum"},{"ns":0,"exists":"","*":"Erythrocyte"},{"ns":0,"exists":"","*":"Erythrocytes"},{"ns":0,"exists":"","*":"Exons"},{"ns":0,"exists":"","*":"FMS-like tyrosine kinase 3 ligand"},{"ns":0,"exists":"","*":"FOXC2"},{"ns":0,"exists":"","*":"Fibrosis"},{"ns":0,"exists":"","*":"Fludarabine"},{"ns":0,"exists":"","*":"Frameshift mutation"},{"ns":0,"exists":"","*":"GATA1"},{"ns":0,"exists":"","*":"GATA2"},{"ns":0,"exists":"","*":"GATA transcription factor"},{"ns":0,"exists":"","*":"GFI1"},{"ns":0,"exists":"","*":"GPR56"},{"ns":0,"exists":"","*":"GPR65"},{"ns":0,"exists":"","*":"G protein coupled receptor"},{"ns":0,"exists":"","*":"Gene"},{"ns":0,"exists":"","*":"Gene expression"},{"ns":0,"exists":"","*":"Gene silencing"},{"ns":0,"exists":"","*":"Genetic disorders"},{"ns":0,"exists":"","*":"Genitourinary system"},{"ns":0,"exists":"","*":"Germline mutation"},{"ns":0,"exists":"","*":"Granulocyte-macrophage colony stimulating factor"},{"ns":0,"exists":"","*":"Granulocyte-macrophage progenitor"},{"ns":0,"exists":"","*":"Granulocytes"},{"ns":0,"exists":"","*":"Haematopoiesis"},{"ns":0,"exists":"","*":"Haploinsufficiency"},{"ns":0,"exists":"","*":"Head and neck cancer"},{"ns":0,"exists":"","*":"Hematologic disease"},{"ns":0,"exists":"","*":"Hematopoiesis"},{"ns":0,"exists":"","*":"Hematopoietic stem cell"},{"ns":0,"exists":"","*":"Hematopoietic stem cell transplantation"},{"ns":0,"exists":"","*":"Hemogenic endothelium"},{"ns":0,"exists":"","*":"Herpes simplex"},{"ns":0,"exists":"","*":"High-throughput sequencing"},{"ns":0,"exists":"","*":"Histoplasma capsulatum"},{"ns":0,"exists":"","*":"Human papillomavirus infection"},{"ns":0,"exists":"","*":"Humoral immune deficiency"},{"ns":0,"exists":"","*":"Hydrocele"},{"ns":0,"exists":"","*":"Hypotelorism"},{"ns":0,"exists":"","*":"Hypothyroidism"},{"ns":0,"exists":"","*":"IKZF1"},{"ns":0,"exists":"","*":"Immune disorder"},{"ns":0,"exists":"","*":"Immune response"},{"ns":0,"exists":"","*":"Immune responses"},{"ns":0,"exists":"","*":"Immune thrombocytopenic purpura"},{"ns":0,"exists":"","*":"Immunodeficiency"},{"ns":0,"exists":"","*":"Infection"},{"ns":0,"exists":"","*":"Innate immune system"},{"ns":0,"exists":"","*":"Insertion (genetics)"},{"ns":0,"exists":"","*":"Interleukin 1 beta"},{"ns":0,"exists":"","*":"Intron"},{"ns":0,"exists":"","*":"Karyotype"},{"ns":0,"exists":"","*":"Karyotyping"},{"ns":0,"exists":"","*":"Kidney cancer"},{"ns":0,"exists":"","*":"LYL1"},{"ns":0,"exists":"","*":"Large granular lymphocytic leukemia"},{"ns":0,"exists":"","*":"Leiomyosarcoma"},{"ns":0,"exists":"","*":"Leukemia"},{"ns":0,"exists":"","*":"Lung function tests"},{"ns":0,"exists":"","*":"Lupus erythematosus"},{"ns":0,"exists":"","*":"Lymphatic system"},{"ns":0,"exists":"","*":"Lymphedema"},{"ns":0,"exists":"","*":"Lymphocyte"},{"ns":0,"exists":"","*":"Lymphopoiesis"},{"ns":0,"exists":"","*":"MPL (gene)"},{"ns":0,"exists":"","*":"MYB (gene)"},{"ns":0,"exists":"","*":"Macrocytosis"},{"ns":0,"exists":"","*":"Macrophages"},{"ns":0,"exists":"","*":"Megakaryocyte"},{"ns":0,"exists":"","*":"Melanoma"},{"ns":0,"exists":"","*":"Miscarriage"},{"ns":0,"exists":"","*":"Molluscum contagiosum virus"},{"ns":0,"exists":"","*":"MonoMAC"},{"ns":0,"exists":"","*":"Monocyte"},{"ns":0,"exists":"","*":"Monocytes"},{"ns":0,"exists":"","*":"Monocytopenia"},{"ns":0,"exists":"","*":"Monocytosis"},{"ns":0,"exists":"","*":"Monosomy"},{"ns":0,"exists":"","*":"Multiple sclerosis"},{"ns":0,"exists":"","*":"Mutation"},{"ns":0,"exists":"","*":"Mutations"},{"ns":0,"exists":"","*":"Myelodysplastic syndrome"},{"ns":0,"exists":"","*":"Myeloproliferative neoplasm"},{"ns":0,"exists":"","*":"N-terminus"},{"ns":0,"exists":"","*":"NK cell"},{"ns":0,"exists":"","*":"NK cells"},{"ns":0,"exists":"","*":"Nasopharynx cancer"},{"ns":0,"exists":"","*":"Negative feedback"},{"ns":0,"exists":"","*":"Neutropenia"},{"ns":0,"exists":"","*":"Neutrophil"},{"ns":0,"exists":"","*":"Neutrophils"},{"ns":0,"exists":"","*":"Non-Hodgkin lymphoma"},{"ns":0,"exists":"","*":"Nontuberculous mycobacteria"},{"ns":0,"exists":"","*":"Nucleic acid sequence"},{"ns":0,"exists":"","*":"Null allele"},{"ns":0,"exists":"","*":"Opportunistic infection"},{"ns":0,"exists":"","*":"PROX1"},{"ns":0,"exists":"","*":"Palpebral fissures"},{"ns":0,"exists":"","*":"Pancreas cancer"},{"ns":0,"exists":"","*":"Panniculitis"},{"ns":0,"exists":"","*":"Penetrance"},{"ns":0,"exists":"","*":"Perilymphatic space"},{"ns":0,"exists":"","*":"Placebo"},{"ns":0,"exists":"","*":"Plasmacytoid dendritic cells"},{"ns":0,"exists":"","*":"Platelet"},{"ns":0,"exists":"","*":"Point mutation"},{"ns":0,"exists":"","*":"Positive feedback"},{"ns":0,"exists":"","*":"Precancerous condition"},{"ns":0,"exists":"","*":"Precursor cell"},{"ns":0,"exists":"","*":"Primary biliary cirrhosis"},{"ns":0,"exists":"","*":"Progenitor cell"},{"ns":0,"exists":"","*":"Progenitor cells"},{"ns":0,"exists":"","*":"Promoter (genetics)"},{"ns":0,"exists":"","*":"Protein"},{"ns":0,"exists":"","*":"Ptosis (eyelid)"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Pulmonary alveolar proteinosis"},{"ns":0,"exists":"","*":"Pulmonary artery hypertension"},{"ns":0,"exists":"","*":"Pulmonary function testing"},{"ns":0,"exists":"","*":"RUNX1"},{"ns":0,"exists":"","*":"Red blood cell"},{"ns":0,"exists":"","*":"Red blood cells"},{"ns":0,"exists":"","*":"Respiratory failure"},{"ns":0,"exists":"","*":"Reticular fibers"},{"ns":0,"exists":"","*":"SETBP1"},{"ns":0,"exists":"","*":"SPI1"},{"ns":0,"exists":"","*":"STAG2"},{"ns":0,"exists":"","*":"Sanger sequencing"},{"ns":0,"exists":"","*":"Semicircular canals"},{"ns":0,"exists":"","*":"Sensorineural hearing loss"},{"ns":0,"exists":"","*":"Spindle cell sarcoma"},{"ns":0,"exists":"","*":"Splice site mutation"},{"ns":0,"exists":"","*":"Stem cell"},{"ns":0,"exists":"","*":"Strabismus"},{"ns":0,"exists":"","*":"Structural motif"},{"ns":0,"exists":"","*":"Survival rate"},{"ns":0,"exists":"","*":"TAL1"},{"ns":0,"exists":"","*":"T cells"},{"ns":0,"exists":"","*":"T helper cells"},{"ns":0,"exists":"","*":"Testes"},{"ns":0,"exists":"","*":"Thrombocytopenia"},{"ns":0,"exists":"","*":"Thrombophilia"},{"ns":0,"exists":"","*":"Total body irradiation"},{"ns":0,"exists":"","*":"Transactivation domain"},{"ns":0,"exists":"","*":"Transcription factor"},{"ns":0,"exists":"","*":"Transcription factors"},{"ns":0,"exists":"","*":"Trisomy"},{"ns":0,"exists":"","*":"Varicella zoster virus"},{"ns":0,"exists":"","*":"Vertebrate"},{"ns":0,"exists":"","*":"Warts"},{"ns":0,"exists":"","*":"Webbed neck"},{"ns":0,"exists":"","*":"Zinc finger"}],"templates":[{"ns":10,"exists":"","*":"Template:Main"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Main"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg"],"externallinks":["//www.ncbi.nlm.nih.gov/pmc/articles/PMC5391620","//doi.org/10.1182/blood-2016-09-687889","//www.ncbi.nlm.nih.gov/pubmed/28179280","//doi.org/10.1007/s12185-017-2285-2","//www.ncbi.nlm.nih.gov/pubmed/28643018","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4926372","//doi.org/10.3390/ijms17060838","//www.ncbi.nlm.nih.gov/pubmed/27248996","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3961519","//doi.org/10.1111/nyas.12346","//www.ncbi.nlm.nih.gov/pubmed/24467820","//doi.org/10.1038/ng.923","//www.ncbi.nlm.nih.gov/pubmed/21892158","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5137783","//doi.org/10.1182/blood-2011-06-360313","//www.ncbi.nlm.nih.gov/pubmed/21765025","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3184204","//doi.org/10.1038/ng.913","//www.ncbi.nlm.nih.gov/pubmed/21892162","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3472596","//doi.org/10.1242/dev.080440","//www.ncbi.nlm.nih.gov/pubmed/23048181","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5650112","//doi.org/10.1053/j.seminhematol.2017.05.002","//www.ncbi.nlm.nih.gov/pubmed/28637621","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5391619","//doi.org/10.1182/blood-2016-09-687871","//www.ncbi.nlm.nih.gov/pubmed/28179282","//doi.org/10.1016/j.exphem.2016.05.010","//www.ncbi.nlm.nih.gov/pubmed/27235756","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3916876","//doi.org/10.1182/blood-2013-07-515528","//www.ncbi.nlm.nih.gov/pubmed/24227816","//doi.org/10.1016/j.semcdb.2018.02.020","//www.ncbi.nlm.nih.gov/pubmed/29452225","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4342850","//doi.org/10.1097/ACI.0000000000000126","//www.ncbi.nlm.nih.gov/pubmed/25397911","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3721406","//doi.org/10.1038/bjc.2013.281","//www.ncbi.nlm.nih.gov/pubmed/23736028","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4512095","//doi.org/10.1590/1414-431X20154557","//www.ncbi.nlm.nih.gov/pubmed/26017341","//doi.org/10.1097/MOH.0000000000000405","//www.ncbi.nlm.nih.gov/pubmed/29278534","//doi.org/10.1002/ajmg.a.33445","//www.ncbi.nlm.nih.gov/pubmed/20803646","//doi.org/10.1080/10245332.2017.1294551","//www.ncbi.nlm.nih.gov/pubmed/28271814","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3739466","//doi.org/10.1093/cid/cit368","//www.ncbi.nlm.nih.gov/pubmed/23728141","//doi.org/10.1007/s10067-015-2905-2","//www.ncbi.nlm.nih.gov/pubmed/25739845","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4402062","//doi.org/10.1002/cam4.384","//www.ncbi.nlm.nih.gov/pubmed/25619630","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3039861","//doi.org/10.1084/jem.20101459","//www.ncbi.nlm.nih.gov/pubmed/21242295","//doi.org/10.1007/s12185-014-1568-0","//www.ncbi.nlm.nih.gov/pubmed/24638828","//doi.org/10.1182/blood-2017-09-765214","//www.ncbi.nlm.nih.gov/pubmed/29438960","//doi.org/10.1182/asheducation-2016.1.598","//www.ncbi.nlm.nih.gov/pubmed/27913534","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5774636","//doi.org/10.1016/j.beha.2017.10.002","//www.ncbi.nlm.nih.gov/pubmed/29156196","//doi.org/10.1111/bjh.14887","//www.ncbi.nlm.nih.gov/pubmed/28875503","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5738979","//doi.org/10.1182/bloodadvances.2016002311","//www.ncbi.nlm.nih.gov/pubmed/29296959","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4323616","//doi.org/10.1016/j.beha.2014.11.004","//www.ncbi.nlm.nih.gov/pubmed/25659730","//doi.org/10.1097/MPH.0000000000000995","//www.ncbi.nlm.nih.gov/pubmed/29189513","//doi.org/10.1182/asheducation-2016.1.302","//www.ncbi.nlm.nih.gov/pubmed/27913495","https://www.ncbi.nlm.nih.gov/gene/2624","https://clinicaltrials.gov/ct2/show/results/NCT00923364?cond=GATA2+deficiency&rank=3&sect=X01256#all","https://clinicaltrials.gov/ct2/show/NCT01861106?term=NCT01861106&rank=1"],"sections":[{"toclevel":1,"level":"2","line":"History","number":"1","index":"1","fromtitle":"GATA2_deficiency","byteoffset":4541,"anchor":"History"},{"toclevel":1,"level":"2","line":"Genetics","number":"2","index":"2","fromtitle":"GATA2_deficiency","byteoffset":6987,"anchor":"Genetics"},{"toclevel":2,"level":"3","line":"<i>GATA2</i> gene mutations","number":"2.1","index":"3","fromtitle":"GATA2_deficiency","byteoffset":7002,"anchor":"GATA2_gene_mutations"},{"toclevel":2,"level":"3","line":"Non-mutational GATA2 deficiency","number":"2.2","index":"4","fromtitle":"GATA2_deficiency","byteoffset":13560,"anchor":"Non-mutational_GATA2_deficiency"},{"toclevel":2,"level":"3","line":"Other genetic abnormalities","number":"2.3","index":"5","fromtitle":"GATA2_deficiency","byteoffset":14421,"anchor":"Other_genetic_abnormalities"},{"toclevel":1,"level":"2","line":"GATA2 transcription factor","number":"3","index":"6","fromtitle":"GATA2_deficiency","byteoffset":17148,"anchor":"GATA2_transcription_factor"},{"toclevel":1,"level":"2","line":"Signs and symptoms","number":"4","index":"7","fromtitle":"GATA2_deficiency","byteoffset":19301,"anchor":"Signs_and_symptoms"},{"toclevel":1,"level":"2","line":"Pathophysiology","number":"5","index":"8","fromtitle":"GATA2_deficiency","byteoffset":25263,"anchor":"Pathophysiology"},{"toclevel":2,"level":"3","line":"Hematologic defects","number":"5.1","index":"9","fromtitle":"GATA2_deficiency","byteoffset":25285,"anchor":"Hematologic_defects"},{"toclevel":2,"level":"3","line":"Immunologic defects","number":"5.2","index":"10","fromtitle":"GATA2_deficiency","byteoffset":29394,"anchor":"Immunologic_defects"},{"toclevel":2,"level":"3","line":"Lymphedema","number":"5.3","index":"11","fromtitle":"GATA2_deficiency","byteoffset":30419,"anchor":"Lymphedema"},{"toclevel":2,"level":"3","line":"Hearing loss","number":"5.4","index":"12","fromtitle":"GATA2_deficiency","byteoffset":30853,"anchor":"Hearing_loss"},{"toclevel":2,"level":"3","line":"Other defects","number":"5.5","index":"13","fromtitle":"GATA2_deficiency","byteoffset":31263,"anchor":"Other_defects"},{"toclevel":1,"level":"2","line":"Presentations","number":"6","index":"14","fromtitle":"GATA2_deficiency","byteoffset":31773,"anchor":"Presentations"},{"toclevel":2,"level":"3","line":"MonoMAC","number":"6.1","index":"15","fromtitle":"GATA2_deficiency","byteoffset":32290,"anchor":"MonoMAC"},{"toclevel":2,"level":"3","line":"Emberger Syndrome","number":"6.2","index":"16","fromtitle":"GATA2_deficiency","byteoffset":33153,"anchor":"Emberger_Syndrome"},{"toclevel":2,"level":"3","line":"Familial MDS/AML","number":"6.3","index":"17","fromtitle":"GATA2_deficiency","byteoffset":34175,"anchor":"Familial_MDS/AML"},{"toclevel":2,"level":"3","line":"Congenital neutropenia","number":"6.4","index":"18","fromtitle":"GATA2_deficiency","byteoffset":36873,"anchor":"Congenital_neutropenia"},{"toclevel":2,"level":"3","line":"Other presentations","number":"6.5","index":"19","fromtitle":"GATA2_deficiency","byteoffset":39144,"anchor":"Other_presentations"},{"toclevel":1,"level":"2","line":"Diagnosis","number":"7","index":"20","fromtitle":"GATA2_deficiency","byteoffset":40656,"anchor":"Diagnosis"},{"toclevel":1,"level":"2","line":"Treatment","number":"8","index":"21","fromtitle":"GATA2_deficiency","byteoffset":42790,"anchor":"Treatment"},{"toclevel":2,"level":"3","line":"Family counseling","number":"8.1","index":"22","fromtitle":"GATA2_deficiency","byteoffset":43342,"anchor":"Family_counseling"},{"toclevel":2,"level":"3","line":"Prevention of complications","number":"8.2","index":"23","fromtitle":"GATA2_deficiency","byteoffset":44298,"anchor":"Prevention_of_complications"},{"toclevel":2,"level":"3","line":"Bone marrow transplantation","number":"8.3","index":"24","fromtitle":"GATA2_deficiency","byteoffset":46067,"anchor":"Bone_marrow_transplantation"},{"toclevel":3,"level":"4","line":"Clinical trials","number":"8.3.1","index":"25","fromtitle":"GATA2_deficiency","byteoffset":47683,"anchor":"Clinical_trials"},{"toclevel":1,"level":"2","line":"Prognosis","number":"9","index":"26","fromtitle":"GATA2_deficiency","byteoffset":48777,"anchor":"Prognosis"},{"toclevel":1,"level":"2","line":"References","number":"10","index":"27","fromtitle":"GATA2_deficiency","byteoffset":49207,"anchor":"References"}],"parsewarnings":[],"displaytitle":"GATA2 deficiency","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q55612175"}]}}